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Australia
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ABSTRACT: Novel tricyclic bridged heterocyclic systems can be readily prepared from
sequential 1,4- and 1,2-addition reactions of allyl and 3-substituted allylsilanes to indolizidine
and quinolizidine -unsaturated N-acyliminium ions. These reactions involve a novel Nassisted, transannular 1,5-hydride shift. Such a mechanism was supported by examining the
reaction of a di-deuterated indolizidine, -unsaturated N-acyliminium ion precursor which
provided specifically di-deuterated tricyclic bridged heterocyclic products and from
computational studies. In contrast, the corresponding pyrrolo[1,2-a]azepine system did not
provide the corresponding tricyclic bridged heterocyclic product and gave only a bis-allyl
adduct, while more substituted versions gave novel furo[3,2-d]pyrrolo[1,2-a]azepine
products. Such heterocyclic systems would be expected to be useful scaffolds for the
preparation of libraries of novel compounds for new drug discovery programs.

1

INTRODUCTION
N-acyliminium ions are well recognized as important reactive intermediates in C-C and Cheteroatom bond forming reactions.1 Both intramolecular1a−c,d,g and intermolecular1a,b,e,f
variants have been extensively developed, with the aforementioned versions providing
synthetic access to novel polycyclic, spirocyclic and bridged heterocyclic ring structures. In
stark contrast, the chemistry of -unsaturated N-acyliminium ions (e.g. 1 in Scheme 1) has
been largely undeveloped.2−4 In principle, these are attractive reactive intermediates for the
one-pot synthesis of novel di-functionalized heterocycles (e.g. 2, Scheme 1) because of their
potential for sequential 1,4- and 1,2-addition reactions with two nucleophiles (Nu1 and Nu2)
under acidic conditions. Significantly, when these two nucleophiles are tethered, or form part
of a latent bis-nucleophile, then novel spirocyclic and bridged heterocycles 2 should be
realized. These types of molecular architectures are common in bioactive natural products4
and therefore such a synthetic strategy would be expected to provide structurally diverse
scaffolds for new drug discovery and natural product synthesis programs. In an earlier
communication we reported the realization of this process for preparing a number of
structurally different spirocyclic compounds.5 We also provided two examples of the
synthesis of bridged heterocycles through the preparation of the novel compounds 5a-8a from
the BF3•Et2O induced reactions of 3a with allyl- and methallyl-trimethylsilane 4 (R = H and
Me, respectively) (Scheme 2).6 We proposed that these bridged products were formed via a
mechanism that involves a transannular 1,5-hydride shift of a carbocation intermediate. We
report here a more extensive study of the scope of these reactions, including a mechanistic
study employing a di-deuterated analogue of 3a and a computational study of the key steps of
these reaction sequences.
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Scheme 1. Proposed reactivity of -unsaturated N-acyliminium ions 1.
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Scheme 2. Synthesis of the novel bridged heterocycles 5-8.
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RESULTS AND DISCUSSION
Synthesis of N-acyliminium ion precursors. The bicyclic N-acyliminium ion precursors 3af, and 13-15, required for this study, were prepared according to Schemes 3 and 4,
respectively. The pyrrolidinone compounds 9a, 9b and 9d (n = 1) (Scheme 3) were prepared
from L-malic acid, while the piperidinone 9d (n = 2) was prepared from (S)-pyroglutamate as
described earlier.5 Compounds 9a-d were then treated with vinylmagnesium bromide to give
the tertiary alcohols 10a-d (the reaction of 9b resulted in cleavage of the acetate group giving
diol 10b). Ring closing-metathesis reactions of 10a-d gave the bicyclic N-acyliminium ion
precursors 3a-d in good to high yields. The tertiary alcohols 3e and 3f were obtained from 3b
by O-tri-isopropylsilylation (TIPSOTf, 2,6-lutidine7) or acetylation (Ac2O, pyridine) (Scheme
3). These compounds were sensitive to degradation and were best prepared just before further
chemical reactions.
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Scheme 3. Synthesis of N-acyliminium ion precursors 3a-f.

Treatment of 3d with p-toluenesulfonic acid in CH2Cl2 at rt for 30 min gave the diene 11 in
81% yield (Scheme 4) which was converted to the endo-peroxide 12 upon treatment with
singlet oxygen (O2, meso-tetraphenylporphyrin (TPP), UV light).8 The stereochemistry of
this compound was deduced from the stereochemistry of its related derivatives 14 (Scheme 4)
and 33 (Scheme 6) which were established by NOE experiments. Compound 12 was
converted to a chromatographically separable mixture of the enone 13 (28% yield) and the diol 14 (41% yield) on treatment with thiourea.8a,9 The configuration at C-9a of 14 was
evident from the NOESY correlation between the resonance for H-9 (6.24, (1H, d, J = 12.0
Hz) and one benzyl methylene resonance at  4.70 (1H, d, J = 12.0 Hz). Reduction of enone
13 with NaBH4/MeOH stereoselectively gave the -alcohol 15.
5

Scheme 4. Synthesis of N-acyliminium ion precursors 13-15.

Reactions of -unsaturated N-acyliminium ions with allylsilanes. In our first set of
experiments, the bicyclic -unsaturated N-acyliminium ion precursor 3a was treated with
allyltrimethylsilane 4 (X = TMS, Y = H) (1.2 equiv.) in the presence of BF3•Et2O (2 equiv.)
in CH2Cl2 solution at 0 oC (Table 1). After a short reaction time (1 h) the adduct 16 could be
isolated in 68% yield as a 1:1 mixture of chromatographically separable diastereomers.
Retreatment of the individual diastereomers of 16 to the above reaction conditions at 0 oC for
1 h and then at rt for 18 h gave the tricyclic bridged compounds 5a (57% yield) and 6a (63%
yield), respectively. Alternatively, treatment of 3a with allyltrimethylsilane/BF3•Et2O,
initially at 0 oC for 1 h and then at rt for 18 h, gave (+)-5a and (-)-6b as a 1:1 mixture of
chromatographically separable diastereomers in 68% yield (Table 1, entry 1). The identity of
these compounds was established by 1D and 2D NMR spectroscopic analysis. The
unexpected position of the alkene group at C-5−C-6 in 5a and 6a was evident from the
multiplicities and the relative deshielded and shielded chemical shifts of H-5 (5a:  7.04 (d, J
= 8.0 Hz); 6a:  7.03 (d, J = 7.0 Hz) and H-6 (5a:  5.06 (apparent t, J = 8.0 Hz); 6a:  5.06
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(apparent t, J = 7.0 Hz), respectively, and the 3-bond correlation between H-5 and the
carbonyl carbon C-3 in the HMBC spectra of both compounds. The configuration of 6a was
established by NOESY experiments which showed a significant correlation between H-1 (
3.81, (1H, apparent t, J = 9.0 Hz)) and one of the methylene bridging protons (H-11) ( 1.43
(1H, d, J = 12.0 Hz)) at C-11. With the aim of improving the diastereoselectivities of these
reactions, other R substituents on the substrate 3 and other allyl nucleophiles were examined.
When the R substituent was changed from Bn to the more hindered TIPS group (3b), the
yield was improved (78%) however the diastereoselectivity remained unchanged (Table 1,
entry 2). The acetate derivative 3c (R = Ac) also offered no improvement in
diastereoselectivity (Table 1, entry 3). This lack of diastereoselectivity was most likely due to
the remoteness of the stereogenic center (C-1) in precursors 3a-c to the site of the first
addition. In contrast, the reactions of 3a with the more hindered allylsilane reagents,
allyltriiso-propylsilane (allylTIPS; 4 (X = TIPS, Y = H)) and allyltert-butyldiphenylsilane
(allylTBDPS), were more diastereoselective (dr 30:70, Table 1, entries 4 and 5). In these
cases 6a was favoured over 5a. The most hindered allyl nucleophile examined, the pinacol
boronate,

4,4,5,5-tetramethyl-2-[(1E)-3-[tris(1-methylethyl)silyl]-1-propen-1-yl]-1,3,2-

dioxaborolane,10 however, showed no diastereoselectivity (Table 1, entry 8). When some of
these reactions were initiated at -78 oC, and then warmed slowly to rt, no improvement in
diastereoselectivities were observed. Allyltributylstanne only produced the initial adduct 16
(72%, dr 1:1, Table 1, entry 9).
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Table 1. Synthesis of bridged tricyclics 5a-c and 6a-c

Entry

R of 3

X, Y of 4

Yield (%)a

1

Bn

TMS, H

68

Diastereoselectivity
(5:6)b
1:1

2

TIPS

TMS, H

78

1:1

3

Ac

TMS, H

70

1:1

4

Bn

TIPS, H

75

30:70

5

Bn

TBDPS, H

62

30:70

6

Bn

PinB, H

71

1:1

7

Bn

KF3B, H

53

1:1

8

TIPS

TIPS, PinB

71

1:1

9

Bn

Bu3Sn, H

72 (16)

1:1

a

Combined yield of 5 and 6 after column chromatography. bDetermined by 1H NMR analysis
of the crude reaction mixture. Pin = pinacol.

We next examined the scope of these reactions towards 2-substituted allyltrimethylsilanes
(Table 2). Under the standard conditions the reaction of 3a with methallyltrimethylsilane (4;
R = Me)/BF3•Et2O gave (+)-7a (R = Me) and (-)-8a (R = Me), respectively, as a 1:1 mixture
of chromatographically separable diastereomers (Table 2, entry 1).
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Table 2. Synthesis of bridged tricyclics 7a-c, 8a-c, 17a-c and 18a-c.

Entry

n

R

Yield of 7 and 8 or
17 and 18 (%)a

Diastereoselectivityb
7:8 or 17:18

1

1

Me

76

1:1

2

1

Ph

61 + 19 (5%)

70:30

3

1

CH2Cl

72

1:1

4

2

H

85

1:1

5

2

Me

83

1:1

6

2

Ph

58

70:30

a

Combined yield of 7 and 8 or 17 and 18 after column chromatography. bDetermined by 1H

NMR analysis of the crude reaction mixture.

Figure 1. 1H NMR correlations for compounds 8a, 17a and 19.
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The configuration of the methyl bearing methine group (C-9) in 8a was established as exo
with respect to the methylene bridge from 1D NOE difference experiments (Figure 1). A
significant NOE was observed between H-1 ( 3.81 (1H, apparent t, J = 9.0 Hz)) and one of
the bridging methylene protons (H-11) ( 1.42, (1H, d, J = 8.0 Hz)) at C-11 and between the
C-9 methyl group ( 0.92, (1H, d, J = 6.0 Hz)) and the other bridging methylene proton (H11) ( 1.95, (1H, d, J = 8.0 Hz)) at C-11. In contrast, the reaction of 3a with 2phenylallyltrimethylsilane11/BF3•Et2O gave not only the bridged products 7b (R = Ph) and 8b
(R = Ph), as a 70:30 mixture of chromagraphically separable diastereomers, but a small
amount (5% isolated yield) of the bridged compound 19 (single diastereomer, Figure 1) in
which the double bond was in the ring arising from the allylsilane component (Table 2, entry
2). The position of the double bond in 19 was evident from the COSY correlation between H7 and H-8 (Figure 1). The analogous reaction of 2-chloromethylallyltrimethylsilane with 3a
gave 7c (R = CH2Cl) and 8c (R = CH2Cl), respectively, as a 1:1 mixture of separable
diastereomers (Table 2, entry 3).
Notably, compounds 6a-c and 8a-b with the methylene bridge between C-7 and C-10a or C-8
and C-11a, respectively, having the -configuration showed small and negative specific
optical rotations and in the 1H NMR spectrum H-1 resonated as a doublet of 5.0 Hz. While
compounds 5a-c and 7a-b, with the methylene bridge having the -configuration, showed a
relatively larger positive specific optical rotation and in the 1H NMR spectrum H-1 resonated
as an apparent triplet of 9.0 Hz. The Ph-substituted derivative 8c, however, had a relatively
large positive specific optical rotation and in the 1H NMR spectrum H-1 resonated as a
doublet of 5.0 Hz. Although we could not obtain unequivocal NOESY or ROESY NMR
evidence for the configuration of this compound we tentatively assigned its structure by
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analogy with 6a-c and 8a-b based on the multiplicity of H-1 ( 3.81, (1H, d, J = 5.0 Hz)) in
its 1H NMR spectrum.
The bridged heterocycles 17 and 18, based on a homologous quinolizinone skeleton, were
readily obtained from the reactions of the quinolizinone derived -unsaturated Nacyliminium ion precursor 3c with allyltrimethylsilanes 4 (R = H, Me, Ph)/BF3•Et2O (Table
2, entries 4-6). For the allyltrimethylsilanes (R = H and Me) the yields of bridged products
17a,b and 18a,b were higher than those for 5a,b and 6a,b from 3a, while the reaction
between 2-phenylallyltrimethylsilane, BF3•Et2O and 3c gave a 70:30 diastereomeric mixture
of chromatographically separable bridged tricycles 17c and 18c (R = Ph), respectively. None
of the product corresponding to the homologue of 19 could be isolated.
The structure of (-)-17a was evident from the NOESY correlation between H-1 ( 3.40, (1H,
s)) and one of the C-11 methylene protons (H-11) ( 1.36 (1H, d, J = 11.0 Hz)) (Figure 1).
While its diastereomer (+)-18a had a specific rotation of opposite sign and H-1 resonated at 
3.38 as a doublet of doublets (J = 4.6, 12.0 Hz)). The same trend in specific rotation and the
multiplicity of the H-1 resonance was found in the diastereomeric pairs of compounds
17b/18b and 17c/18c.
Deuterium labeling studies. To support our initially proposed mechanism to explain the
formation of the bridged products 5-8, the di-deuterated analogue 20 (Scheme 5) of the Nacyl iminium ion precursor 3a was prepared via the corresponding di-deuterated analogues of
9a and 10a. The former derivative was prepared from the condensation reaction between but3-en-1,1-d2-1-amine12 and L-malic acid (see the Experimental section for details). Treatment
of 20 with methallyltrimethylsilane/BF3•Et2O gave the specifically labeled di-deuterated
bridged products 26 and 27 in 75% yield as a 1:1 mixture of diastereomers (Scheme 5). These
could be separated by further column chromatography. The positions of the deuterium labels
11

in these compounds were clearly apparent from 1H and 13C NMR spectroscopic analysis. For
example, in the 1H NMR spectrum of 26, the resonance associated with the methyl
substituent was now observed as a singlet at 0.84 (3H) While the resonance associated with
the most deshielded enamide proton at H-5 in 7a was completely absent and the multiplicity
of the other enamide proton (H-6) had changed from a doublet of doublets in 7a (R = Me) to
a doublet resonance (5.10, J = 6.0 Hz)) in the 1H NMR spectrum of 26. Further, in the 13C
NMR spectrum of 26, resonances associated with the enamide carbon C-5 (123.0 (t, JC-D =
26.8 Hz)) and the methine carbon C-9 (24.5 (t, JC-D = 19.3 Hz)) showed JC-D coupling.
Scheme 5. Deuterium labeling studies on 20
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Related differences in the NMR spectra of 27 when compared to those of 8a were also
observed.
These labeling studies support the mechanism outlined in Scheme 5. The reaction of 20 with
BF3•Et2O gives the -unsaturated N-acyliminium ion intermediate 21 which undergoes a
1,4-addition reaction with the allylsilane reagent to give the initial adduct 22 (Scheme 5).
This compound then undergoes protonation (by HOBF3- or its derivative) to generate the Nacyliminium ion 23 which upon an intramolecular cyclization reaction (1,2-addition reaction)
gives the tricyclic carbocation intermediate 24. This intermediate undergoes a transannular
1,5-hydride shift to give the N-stabilized carbocation intermediate 25, and its diastereomer,
which then give the enamides 26/27 upon loss of a proton. Such transannular 1,5-hydride
shifts have precedent.13 Cases involving N-stabilization however, are rare. In the case of the
reaction of 3a with 2-phenylallyltrimethylsilane/BF3•Et2O a small amount of the tricyclic
compound 19 was also isolated, resulting from elimination of a proton from the nondeuterated, phenyl analogue of intermediate 24. In this intermediate, the Ph substituent
stabilizes the carbocation such that the 1,5-hydride transfer mechanism is relatively slower
allowing a small amount of the 1,2-elimination product (19) to form.
Computational studies. In order to explore the mechanism of this sequence in more detail,
the key reaction steps, e.g. (i) the allylsilylane addition to the -unsaturated N-acyliminium
ion precursor, and (ii) the subsequent nucleophilic cyclization/1,5-hydride shift were studied
with computational methods. Geometry optimizations and frequency analyses for all ground
and transition state structures were performed using the B3LYP14 and M06-2X15 density
functional methods, in combination with the 6-31G* and 6-31+G* basis sets16 using the
Gaussian09 software package.17 Selected reactions were also computed with the M06-2X/631+G* method using the D3 version of Grimme’s dispersion with the original D3 damping
function.18 Calculations in dichloromethane were performed for selected reactions using the
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Conductor-like Polarizable Continuum Model (CPCM).19 All ground and transition states
were verified by vibrational frequency analysis at the same level of theory, and all identified
transition states showed only one imaginary frequency.
To gain insight into the diastereoselectivity of the allylation step, we explored the addition
from the same (syn) and opposite side (anti) of the pyrrolidinone ring substituent (OR' in B).
The results are compiled in Table 3 for various model allylsilanes A and unsaturated Nacyliminium ions B.

Table 3. Addition of allylsilanes A to -unsaturated N-acyliminium ions B: Calculated
potential energy surface and distance (d) between reaction centers in transition state
TS1 (free energies in kJ mol-1).a

d/Å

C

Entry

R

R'

R″

TS1

1b

H

Me

H

83.2

1.924

81.2 (syn)

2c

H

Me

H

69.0

2.027

47.0 (syn)d

3e

H

Me

H

88.8

2.110

37.3 (syn)d

4f

H

Me

H

72.0g

2.025

44.4 (syn)d

14

5h

H

Me

H

86.2

2.110

34.9 (syn)d

6b

H

Me

H

99.8

1.974

86.1 (anti)

7c

H

Me

H

89.5

2.058

53.2 (anti)d

8e

H

Me

H

100.0

2.126

37.5 (anti)d

9f

H

Me

H

87.2

2.056

50.6 (anti)d

10h

H

Me

H

97.6

2.124

35.0 (anti)d

11b

H

Bn

H

78.8

1.913

85.6 (syn)

12b

H

Bn

H

104.1

1.962

91.6 (anti)

13b

iPr

Me

H

56.1

2.124

23.4 (syn)d

14b

iPr

Me

H

62.7

2.120

22.7 (anti)d

15b

iPr

Bn

H

63.6

2.126

30.1 (syn)d

16b

iPr

Bn

H

68.5

2.105

29.7 (anti)d

17b

H

Me

Ph

41.7

2.313

7.7 (syn)

18b

H

Me

Ph

49.4

2.236

8.1 (anti)

19b

Me

Me

Ph

37.4

2.394

-12.1 (syn)

20c

Me

Me

Ph

--i

--

-38.5 (syn)

21e

Me

Me

Ph

--i

--

-29.7 (syn)

22b

Me

Me

Ph

35.9

2.195

-20.0 (anti)

23c

Me

Me

Ph

17.6

2.154

-48.4 (anti)d

24e

Me

Me

Ph

30.9

2.183

-46.1 (anti)d

a

G values are relative to compound reactants A and B. bB3LYP/6-31G*. cM06-2X/6-31+G*.
d
Elongated C–Si bond (see text). eM06-2X/6-31+G* in dichloromethane. fM06-2X/6-31+G*
with D3 dispersion. gTransition state associated with two negative vibrations (see text).

15

h

M06-2X/6-31+G* with D3 dispersion in dichloromethane. iTransition state could not be
located (see text).

According to the computational predictions, the reaction likely occurs through initial
formation of a reactant complex, which is ca 20 kJ mol-1 higher in energy than the free
reactants (data not shown). Comparison of the data in entries 1-5 and 6-10 show some
variation of the data with the level of theory. Thus, the gas phase computations using the
M06-2X/6-31+G* method, which has been shown to address standard non-covalent
interactions with reasonable accuracy,20 predict TS1 about 10-15 kJ mol-1 below the values
obtained with B3LYP/6-31G*, which, on the other hand, computes energies for TS1 similar
to M06-2X/6-31+G* in dichloromethane. Inclusion of the D3 dispersion correction in the
M06-2X calculations does not lead to significantly different energies (entries 4, 5 and 9, 10).
However, it should be noted that TS1 in entry 4 is characterised by two negative frequencies.
Thus, the vibrational mode associated with the addition (-345.3 cm-1) is accompanied by a
very weak negative vibration (-2.7 cm-1) that corresponds to a rocking motion of the two
molecular fragments and which cannot be eliminated. The considerably lower energy of
product C (and therefore lower endothermicity of the addition process) predicted by M06-2X
for both gas phase and in dichloromethane could be due to a slightly different geometry of C
that is characterised by a considerably elongated C-SiH3 bond (2.05 – 2.09 Å) and shortened
C–C bond (1.38 Å), compared to B3LYP (C-SiH3: 2.02 Å; ‘C-C’: 1.41 Å). Overall, except
for the reaction system in entries 19-24 (see below), all of these methods predict that both syn
and anti addition are energetically very similar with the syn pathway being slightly more
favourable by a few kJ mol-1.
A considerable influence of the substitution pattern in allylsilane A on the energy profile of
the addition process is apparent. Thus, increasing the electron density at Si by replacing H
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with alkyl substituents lowers the transition state for the addition, TS1, and renders the
reaction energetically more favourable. This can be rationalized by the -silicon effect, which
stabilizes cations  to the Si atom through hyperconjugation.21 In fact, the optimized
structures for C with R = iPr indicate an advanced dissociation into iPr3Si+ and the
corresponding alkene (C–SiR3 distance = 2.15 Å), e.g. formation of the product of type 16
(see Table 2). Additional stabilization of the positive charge in C, e.g. when R'' = Ph (entries
17-24), further lowers the energy of both TS1 and C.
Analysis of the TS1 geometry reveals that, irrespective of the theoretical level, in systems
with low steric hindrance the distance (d) between the reaction centers for the syn addition is
slightly shorter than for the anti attack. It is apparent that steric effects due to the ‘remote’
substituents R on the allylsilane and R' at the stereocenter in B are too small to induce
considerable face discrimination in TS1. The system has sufficient conformational flexibility
that, even when R' = Bn, addition of the allylsilane could occur in both syn and anti fashion
in such way that steric hindrance can be largely avoided. This is further supported by the
energies of adduct C, which are very similar for the syn and anti addition when R” = H.
Interestingly, increasing the size of the substituent R” from H to Ph results in a considerably
elongated distance between the reaction centers by 0.1-0.2 Å for the syn addition and also a
slight elongation for the anti attack, which is indicative for an earlier transition state. This
corresponds well with the computed lower barrier for the reactions involving the 2-phenyl
substituted allylsilanes and the stronger exothermicity of these reactions, in accordance with
the Hammond postulate.22
According to the B3LYP computations, TS1 for syn and anti addition addition of A to B for
R = R' = Me and R'' = Ph are very similar, indicating a non-diastereoselective reaction (entry
19 vs. 22). The M06-2X method reveals the same trend on TS1 for both for gas phase and in
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dichloromethane for the anti attack as for the other systems studied in this work. However, it
is worth noting that TS1 for the syn addition could not be located with M06-2X (entries 20
and 21). The experimentally observed formation of 7b as the major diastereomer that is
formed through anti allylation of 3a (Table 2, entry 2) can be rationalised by the stability of
the corresponding adduct C. Thus, irrespective of the level of theory, the calculations predict
syn-C as an ‘intact’ molecule with a covalent C–Si bond (C–SiMe3 distance ca. 2.02 Å). In
contrast to this, the M06-2X calculations reveal a clearly elongated C–Si bond in the
corresponding anti-C (C–SiMe3 distance ca. 2.06 Å), indicating partial dissociation into the
final alkene of type 16. We believe that formation of syn-C is reversible, and equilibration
leads ultimately to the thermodynamically more stable anti-C. In contrast to this, in the case
of less stabilized adducts C the subsequent desilylation through C–Si bond cleavage should
be faster than reverse fragmentation into A and B, so that a kinetically controlled product
distribution is obtained.
We next explored the energy profile for the subsequent nucleophilic cyclization/1,5-hydride
shift. The calculated data for the model system D  E  F are shown in Table 4.
Table 4. Calculated potential energy surface for the nucleophilic cyclization/1,5-hydride
shift D  E  F (free energies in kJ mol-1).a,b

Entry
1c

R'
Me

R″

m,n

TS2

E

TS3

F

TS4

H

1,1

‐‐d

‐‐ d

‐‐ d

‐65.0

70.4

18

2e

Me

H

1,1

‐‐ d

‐‐ d

‐‐ d

‐91.2

63.6

3f

Me

H

1,1

‐‐ d

‐‐ d

‐‐ d

‐84.8

54.0

[4c

Me

H

1,1

‐‐ d

‐‐ d

‐‐ d

‐22.2

74.4] g

5c

Me

Me

1,1

53.1

43.3

45.9

‐53.5

6e

Me

Me

1,1

42.6

28.7

29.3

‐82.6

7f

Me

Me

1,1

42.1

3.4

19.7

‐76.5

[8c

Me

Me

1,1

57.2

42.6

48.9

2.7] g

[9e

Me

Me

1,1

44.9

27.0

32.4

‐21.5]g

[10f

Me

Me

1,1

50.5

11.5

27.0

‐19.3]g

11c

Me

Ph

1,1

28.5

‐6.3

24.1

‐51.7

12e

Me

Ph

1,1

18.4

‐8.8

12.1

‐81.6

13f

Me

Ph

1,1

31.9

‐11.9

19.0

‐76.7

[14c

Me

Ph

1,1

42.7

2.2

39.3

14.9]g

[15e

Me

Ph

1,1

35.2

‐2.6

25.8

‐15.1]g

[16f

Me

Ph

1,1

51.0

‐0.1

36.3

‐13.5]g

17c

Me

CH2Cl

1,1

87.4

79.3

81.0

‐39.9

[18c

Me

CH2Cl

1,1

77.4

67.9

69.9

3.3]g

19c

Bn

Me

1,1

55.0

41.8

46.4

‐54.0

[20c

Me

Me

1,2

89.2

85.8

‐‐c

13.8]g

[21h

Me

Me

1,2

76.7

70.8

‐‐d

‐17.0]g

22c

Me

Me

2,1

55.8

53.6

‐‐d

‐33.4

a

G vaiues are relative to compound D. bScheme shows formation of the -configuration at
the methylene bridge, which results from cyclization of the anti isomer. cB3LYP/6-31G*.
d
Could not be located. eM06-2X/6-31+G*. fM06-2X/6-31+G* in dichloromethane. gData in
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square brackets are for cyclization of the syn isomer that leads to the-configuration at the
methylene bridge. hM06-2X/6-31G*.

When D has a non-branched propene substituent (R'' = H), the computations predict a onestep process via TS4 for the rearrangement (entries 1 – 4). A stable ground state structure of
the cationic intermediate E could not be located with neither the B3LYP/6-31G* (entries 1
and 4) nor the M06-2X/6-31+G* method for both gas phase (entry 2) and in dichloromethane
(entry 3), respectively. The concerted nature of the cyclization/rearrangement D  F was
confirmed through intrinsic reaction coordinate calculations (IRC) at the B3LYP/6-31G*
level. When R''  H the stability of E increases, and ground state structures could be located.
The gas phase calculations predict for R'' = alkyl that formation of the intermediate E is an
endothermic process. This is plausible, since the resonance stabilization of the positive charge
in carbocation D is lost upon cyclization to E. However, as shown by the exemplary
calculations for D with R'' = Me, the intermediate E experiences a considerable stabilization
in dichloromethane (entries 7 vs. 5, 6 and 10 vs. 8, 9). Thus, cyclization of anti-D (with R' =
R'' = Me) to E becomes a practically energy neutral process (entry 7), whereas the
corresponding cyclization of syn-D is slightly more endothermic (entry 10). In fact, a
stabilizing effect of the solvent is apparent throughout the sequence D  F, which leads not
only to lower energies for TS2 and TS3 in general, but also to a significant stabilization of all
ground states, compared to the gas phase. This has implications for the rearrangement E  F
though TS3, where the gas phase calculations predict a rapid process through a very low
barrier, whereas in dichloromethane this process is slower. It is, however, important to point
out that, irrespective of the theoretical method, the sequence anti-D  -F is kinetically and
thermodynamically more preferred than syn-D  -F. Further, it is reasonable to assume that
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the subsequent deprotonation of F to yield stable products of type 5-8 will be very fast,
providing ultimately the thermodynamic driving force for the overall sequence.
In the case of R'' = Ph cyclization of D leads to the resonance stabilized intermediate E in an
exothermic reaction (entries 11-16). Rearrangement of the latter to F through hydride
migration is also exothermic, but associated with a considerable activation barrier (TS2).
Because of this, competing reactions can occur, for example deprotonation, which explains
formation of by-product 20 in the reaction of 3a with 4 (R = Ph, see Table 2). However,
contrary to the system with R' = alkyl described above, the influence of solvent on TS2, TS3
and E is less pronounced. Exploration of the reason for the different outcome clearly requires
further investigations, which are beyond the scope of the present study. However, in general
the M06-2X/6-31+G* calculations for both gas phase and in dichlormethane predict
formation of F being about 20-30 kJ mol-1 more exothermic than the gas phase B3LYP/631G* method.
The computed higher energies for TS2, D and TS3 in the case of R” = CH2Cl (entries 17, 18)
can be attributed to the fact that the cyclization/rearrangement process involves development
of an energetically unfavourable positive charge  to the electron-withdrawing chloromethyl
substituent.
Similar to the addition of allylsilane A to N-acyliminium ion B, the substituent R' in the
pyrrolidinone does not influence the reaction outcome (entry 19 vs. 5). Inspection of the
geometries of D, E and TS2 (not shown) reveals that even the large OBn substituent has
sufficient conformational flexibility to avoid steric interactions with the allyl side chain.
Evaluation of the experimental findings and the computational predictions presented in
Tables 3 and 4 clearly indicate that the diastereoselectivity of the entire sequence is
determined by the addition of the allylsilane to the -unsaturated N-acyliminium ion B and
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the stability of the intermediate cation C. Thus, when R'' = H, Me (or CH2Cl), this addition is
largely unselective, leading to a 1:1 mixture of products (5 + 6 and 7 + 8, respectively). In the
case of R'' = Ph, the major product 7 possesses the -configuration at the methylene bridge
(Table 2, entry 2). As mentioned above, this can be rationalised by the preferred formation of
the respective anti-C intermediate, which is further amplified by its faster subsequent
rearrangement through nucleophilic cyclization/1,5-hydride transfer (Table 4, entries 11-13
versus 14-16). On the other hand, the preferential formation of 6 possessing the configuration at the methylene bridge (Table 1, entries 4 and 5) is less obvious. There seems
to be a not yet understood directing effect of the bulky silyl group that supports syn addition
of the allylsilane, which warrants further investigation.
It should be noted that increasing the size of either of the rings in the -unsaturated Nacyliminium ion affects the entire sequence considerably. Thus, according to the
computations, the barrier TS2 and the energy of intermediate E in the homologous
quinolizinone (m = 1, n = 2) are both higher than for the smaller homologue (entry 20 and 21
vs. 8-10). Although a transition state for the 1,5-hydride shift could not be located, the
distance between the carbon centres involved in this transfer is significantly larger than in the
smaller indolizidinone derived intermediate E (3.241 Å vs. 2.268 Å). This indicates that for
the hydride transfer to occur in the quinolizinone derived intermediate E, considerable
conformational changes are required.
In the case of pyrrolo[1,2-a]azepines (D with m = 2, n = 1), the B3LYP/6-31G* computations
predict that the nucleophilic cyclization should principally occur at a similar rate than in the
indolizidines. However, TS3 for the corresponding subsequent transannular hydride shift
could not be located (Table 4, entry 22). In fact, inspection of the geometry (not shown)
reveals that the ‘reactive’ conformation would require eclipsed adjacent methylene groups,
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which is energetically highly unfavourable. This prediction was confirmed experimentally.
Thus in contrast to the chemistry found on the aforementioned indolizidinone (3a-b) and
quinolizinone (3c) systems, the pyrrolo[1,2-a]azepines 3d and 13-15 also gave some highly
unexpected reaction products (Scheme 6).
Reactions of pyrrolo[1,2-a]azepines. The reaction of the bicyclic -unsaturated Nacyliminium ion precursor 3d with allyltrimethylsilane (1.2 equiv.)/BF3•Et2O gave a low
yield (34%) of the bis-allylated product 28 as a single diastereomer (Scheme 6(a)). Other
products were formed but could not be isolated in sufficient purities for characterization. The
configuration assigned to C-9a in 28 was based on the significant NOE correlation between
the resonances for H-1 and H-9. Our attempts at a ring-closing metathesis reaction of 
with Grubbs’ first or second generation Ru catalysts (CH2Cl2, rt to reflux or toluene at 80 oC)
resulted in only recovered starting material, which indicated that the two allyl groups may
have an anti stereochemical relationship as shown in structure 28.
The reactions of 13 with allyl- and methallyl-trimethylsilane/BF3•Et2O gave the highly
conjugated tricyclic trieneones (furo[3,2-d]pyrrolo[1,2-a]azepines) 29 and 30, respectively
(Scheme 6(b)). In both products elimination of the OBn group had occurred and, surprisingly
in 29 the TMS group of the allyltrimethylsilane had been retained, while in 30 this group had
been lost to form part of a gem-dimethyl substituent. A possible mechanistic scheme to
explain the formation of these products is provided in Scheme 7(a). 1,4-Addition of
allyltrimethylsilane to the -unsaturated N-acyliminium ion intermediate formed from 13
would give the cationic intermediate 35, stabilized by the -TMS group. This cation is
Scheme 6. Reactions of pyrrolo[1,2-a]azepines
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O

N
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H
HO

H
33: 76% from 14 or
75% from 32
(
NOE)

34

trapped by the enol form of the proximal ketone group of 35 to give the tetrahydrofuran
intermediate 36. Furan-oxygen assisted elimination of benzyl alcohol from the protonated
intermediate 37 followed by loss of a proton would then lead to the observed product 29 with
retention

of

the

TMS

group.

In

the

case

of

the

reaction

of

13

with

methallyltrimethylsilane/BF3•Et2O the analogous incipient cationic intermediate to 35 is more
sterically hindered to attack by the ketone and thus more readily loses the TMS group to give
the alkene intermediate 39 (Scheme 7(b)). Protonation of the alkene group then gives the
tertiary cation intermediate 40 which can undergo a similar sequence of reaction events as
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intermediate 35 to give the observed tricyclic product 30. The -alcohol analogue 15 of 13
gave

a

similar

tricyclic

product

31

in

47%

yield

upon

reaction

with

allyltrimethylsilane/BF3•Et2O, with retention of the TMS group and the O-benzyl substituent.
The configuration at C-2, C-3a and C-10a in 31 was evident from NOESY NMR experiments
which showed mutual NOE correlations between H-2, H-3a and H-10a (Scheme 6(c)). This
seems to be the first report of the synthesis of a furo[3,2-d]pyrrolo[1,2-a]azepine.
Scheme 7. Proposed mechanisms for the formation of compounds 29 and 30

In contrast, the reaction of allyltrimethylsilane with 14 gave the adduct 33 in 76% yield as a
single diastereomer (Scheme 6(d)). This product was formed via the tricyclic intermediate 32
which could be isolated in 80% yield after quenching the reaction after a short reaction time
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at 0 oC. Treatment of 32 with allyltrimethylsilane/BF3•Et2O at rt gave the allylated product 33
in 75% yield. The stereochemistries of 32 and 33 were established by NOE experiments
which showed significant correlations between the resonances for the benzyl protons and the
alkene proton H-9 and the vicinal methines shown on structures 32 and 33, respectively
(Scheme 6(d)). Compound 33 could not be induced to cyclize to the bridged compound 34 by
further treatment with BF3•Et2O or protic acids (TFA, TsOH or formic acid). Only unreacted
33 was recovered from these reactions.
To

examine

further

reactions

of

the

indolizidine

3a

it

was

treated

with

propargyltrimethylsilane23 to give a 2:1 mixture of allene diastereomers 41 (Scheme 8(a))
The major diastereomer cyclized upon exposure to formic acid at 60 oC24 to give, after base
treatment, the novel bridged tricyclic ketone 42 in 57% yield. The stereochemistry of 42 was
assigned from ROESY NMR analysis which showed a correlation between the resonance for
H-1 ( 3.77 (1H, t, J = 6.5 Hz) and the resonance for one of the diastereotopic C-10 protons
(H-10 2.41 (1H, d, J = 17.5 Hz)) (Scheme 8(a)). The “anti” stereochemistry of the major
diastereomer of 41 is analogous to that of the major diastereomer of the diene 43 formed from
the reaction of 3a with (E)--styreneboronic acid/BF3•Et2O.25 This major diastereomer
underwent a diastereoselective reduction with NaCNBH3/HOAc to give the disubstituted
indolizidinone 44 (Scheme 8(b)) in which the configurations at the newly formed stereogenic
centers could be assigned from NOE experiments. The NOE correlations between the
resonances for H-7 and H-8a indicated these protons had a 1,3-diaxial relationship, while the
NOE correlation between the resonances for H-8a and the OBn methylenes indicated that
these protons and H-7 were all on the same face of the indolizidinone ring (Scheme 8(b)).
Thus the reduction of the N-acyl iminium intermediate formed from protonation of the
enamide of 43, in the conversion of 43 to 44, is a result of the expected axial attack by this
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hydride reducing agent from the -face through a transition state conformation in which the
C-1 and C-7 substituents are pseudo-equatorial.26
Scheme 8. Synthesis of indolizidinone derivatives 41−44
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CONCLUSIONS
In conclusion, novel tricyclic bridged heterocyclic systems can be readily prepared from
sequential 1,4- and 1,2-addition reactions of allyl- and 2-substituted-allylsilanes to
indolizidine and quinolizidine unsaturated N-acyliminium ions. These reactions involve
a novel N-assisted transannular 1,5-hydride shift. Such a mechanism was supported by
examining the reaction of a di-deuterated -unsaturated N-acyliminium ion precursor
which provided specifically di-deuterated tricyclic bridged heterocyclic products and from
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computational studies. The latter study indicated that the transannular 1,5-hydride shift
proceeds rapidly with a very low or virtually non-existent activation barrier. Overall,
according to the computations, the diastereoselectivity of the entire sequence is determined in
the allylation of the -unsaturated N-acyliminium ion, which leads to the corresponding
adducts syn/anti-C in a kinetically controlled fashion. In the case of highly stabilized
carbocations, it is proposed that the allylation is reversible and leads ultimately the
thermodynamically most stable adduct. In contrast, an -unsaturated N-acyliminium ion
derived from the corresponding pyrrolo[1,2-a]azepine system did not provide the
corresponding tricyclic bridged heterocyclic product and gave only a bis-allyl adduct, while
more substituted versions gave novel furo[3,2-d]pyrrolo[1,2-a]azepine products. The reaction
of

an

indolizidine-unsaturated

ion

N-acyliminium

precursor

with

propargyltrimethylsilane gave an allenyl adduct which could be cyclized with formic acid to
a novel bridged tricyclic ketone. Such bridged tricyclic heterocyclic systems would be
expected to be very useful scaffolds for the future preparation of libraries of novel
compounds for new drug discovery programs. Such investigations are now in progress.
EXPERIMENTAL
General methods. Unless stated, CDCl3 was used as a solvent for all 1H NMR (H, 500
MHz) and 13C NMR (C, 125 MHz) measurements. The following abbreviations were used: s
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, and br=
broard. All coupling constants (J) are measured in hertz (Hz). Chemical shifts are reported in
parts per million (ppm) from tetramethylsilane and are corrected to 0.00 (TMS) ppm for 1H
NMR and 77.00 (CDCl3 center line) for

13

C NMR. 1H and

13

C NMR assignments for all

compounds are given in the Supporting Information and are based on COSY, HSQC and
HMBC experiments and in some cases NOESY/ROESY experiments. Optical Rotations were
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measured at 25 oC in chloroform (λ = 589 nm). Infrared spectra were obtained on neat
samples and major bands are reported in wavenumbers (cm-1). High resolution mass spectra
(HRMS) were obtained using a Q-TOF mass spectrometer.
All reactions using air/moisture sensitive reagents were performed in an oven dried
apparatus, under an atmosphere of dry nitrogen. Anhydrous THF was obtained by distillation
from sodium/benzophenone. Anhydrous CH2Cl2 and toluene were obtained as commercial
samples or from an anhydrous solvent dispenser. Column chromatography was performed
using silica gel (35-70 µm) and the solvents specified. Petrol refers to the hydrocarbon
fraction of bp 40-60 oC.
Synthesis of N-acyliminium ion precursors 3a-f.
Compounds 3a, 10a and 10d were prepared as described previously.5
(S)-N-(But-3-en-1-yl)-5-oxotetrahydrofuran-2-carboxamide

To a solution of (S)-oxotetrahydrofuran-2-carbonyl chloride27 (0.950 g, 6.41 mmol) in
CH2Cl2 (30 mL) was added Et3N (0.972 g, 9.61 mmol) and 4-butenylamine5 (0.455 g, 6.41
mmol) at 0 oC. The resulting mixture was stirred at rt for 16 h then it was quenched with
water (30 mL). The aqueous layer was extracted with CH2Cl2 (3x20 mL), dried (MgSO4) and
concentrated in vacuo. Column chromatography (2:1, EtOAc/petrol) of the crude product
afforded the title compound (0.740 g, 63%) as a yellow oil.

- 16.8 (c 0.8 CHCl3).

vmax/cm-1 3012, 1684, 1399, 1375, 1101, 1126, 919. H 6.54 (1H, br. s, NH), 5.79-5.71 (1H,
m), 5.10 (1H, d, J = 17.5 Hz), 5.09 (1H, d, J = 10.0 Hz), 4.85 (1H, t, J = 7.0 Hz), 3.38 (2H, q,
J = 6.5 Hz,), 2.66-2.59 (1H, m), 2.57-2.54 (2H, m), 2.39-2.33 (1H, m), 2.31-2.27 (2H, m). C
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175.7, 169.1, 134.6, 117.3, 77.3, 38.0, 33.4, 27.3, 25.7. HRMS (ESI) m/z calcd for C9H14NO3
[M + H]+ 184.0974, found 184.0977.
(S)-1-(But-3-en-1-yl)-3-hydroxypiperidine-2,5-dione

(S)-N-(But-3-en-1-yl)-5-oxotetrahydrofuran-2-carboxamide (0.500 g, 2.73 mmol) was
dissolved in THF (20 mL) and the solution was cooled to -78 oC. t-BuOK (0.153 g, 1.36
mmol) was then added portionwise at this temperature and the resulting suspension was
warm to -58 oC over 1 h. Water (15 mL) was added and the aqueous layer was extracted with
Et2O (2x20 mL). The combined organic extracts were dried (MgSO4) and concentrated in
vacuo. Column chromatography (1:1, EtOAc/petrol) yielded the desired product (0.334 g,
67%) as a colorless oil.

- 22.3 (c 0.2 CHCl3). vmax/cm-1 3446, 1683, 1397, 1345, 1172,

1123, 915. H 5.77-5.69 (1H, m), 5.03-5.00 (2H, m), 4.21 (1H, dd, J = 5.5, 12.5 Hz), 3.923.82 (2H, m), 3.71 (1H, s, OH), 2.90-2.85 (1H, m), 2.67-2.59 (1H, m), 2.33-2.29 (3H, m),
1.93-1.84 (1H, m). C 175.1, 171.1, 134.5, 117.1, 68.2, 39.2, 32.1, 30.7, 25.2. HRMS (ESI)
m/z calcd for C9H14NO3 [M + H]+ 184.0974, found 184.0973.
(S)-3-(Benzyloxy)-1-(but-3-en-1-yl)piperidine-2,6-dione (9c). To a solution of (S)-1-(but-3en-1-yl)-3-hydroxypiperidine-2,5-dione (0.300 g, 1.63 mmol) and BnBr (0.560 g, 3.27 mmol)
in Et2O (30 mL) was added Ag2O (0.755 g, 3.27 mmol) at rt. The resulting suspension was
stirred in the dark at rt for 16 h then filtered through a pad of Celite® using Et2O as eluent.
The residue was concentrated in vacuo and purified by column chromatography (1:5,
EtOAc/petrol) to give the title compound (0.391 g, 88%) as a colorless oil.
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- 46.1 (c 0.5

CHCl3). vmax/cm-1 1697, 1437, 1353, 1110, 912, 758, 676. H 7.35-7.29 (5H, m), 5.77-5.71
(1H, m), 5.02 (1H, d, J = 17.5 Hz), 4.99 (1H, d, J = 10.5 Hz), 4.86 (1H, d, J = 12.0 Hz), 4.66
(1H, d, J = 12.0 Hz), 4.03 (1H, t, J = 6.0 Hz), 3.82 (2H, t, J = 7.0 Hz), 2.91-2.85 (1H, m),
2.58-2.52 (1H, m), 2.30-2.26 (2H, m), 2.05-2.02 (2H, m) C 171.4, 171.2, 137.1, 134.7,
128.3, 127.8, 127.7, 116.7, 73.6, 72.2, 38.6, 32.6, 28.9, 23.9. HRMS (ESI) m/z calcd for
C16H20NO3 [M + H]+ 274.1436, found 274.1433.
(4S,5S)-1-(But-3-en-1-yl)-4,5-dihydroxy-5-vinylpyrrolidin-2-one (10b). To a solution of (S)1-(but-3-en-1-yl)-2,5-dioxopyrrolidin-3-yl acetate5 (1.200 g, 4.39 mmol) in THF (40 mL) at 0
o

C was added vinylmagnesium bromide (1.0 M in THF, 13.18 mmol) dropwise. The resulting

mixture was stirred at that temperature for a further 2 h before it was quenched with NH4Cl
(saturated aqueous solution). The aqueous layer was extracted with Et2O (2x20 mL) and the
combined organic layers were dried (MgSO4) and concentrated in vacuo. The crude product
was purified by column chromatography (1:1.5 EtOAc/petrol) yielding the title compound
(0.536 g, 62%) as a colorless oil and as a mixture of diastereomers (23:77). A small amount
of each isomer could be obtained in pure form by further separation by column
chromatography. Major isomer:

+ 27.9 (c 1.3 CHCl3). vmax/cm-1 3364, 1689, 1395,

1343, 987, 927, 735, 696. H 6.15 (1H, dd, J = 10.5, 17.0 Hz), 5.80-5.74 (1H, m), 5.78 (1H, d,
J = 17.0 Hz), 5.58 (1H, d, J = 10.5 Hz), 5.15-5.05 (2H, m), 4.60 (1H, t, J = 5.0 Hz), 3.47 (1H,
quintet, J = 6.5 Hz), 3.04 (1H, quintet, J = 6.5 Hz), 2.90 (1H, s, OH), 2.76 (1H, dd, J = 6.5,
17.0 Hz), 2.40 (1H, dd, J = 5.0, 17.0 Hz), 2.35-2.30 (2H, m); C 172.8, 134.2, 136.1, 117.3,
117.0, 92.5, 70.4, 38.4, 36.0, 31.3. HRMS (ESI) m/z calcd for C10H16NO3 [M + H]+
+ 32.8 (c 0.6 CHCl3). vmax/cm-1 3324, 1669,

198.1173, found 198.1176. Minor isomer:

1399, 1091, 986, 921, 730, 691. H 5.78-5.72 (2H, m), 5.51 (1H, d, J = 17.0 Hz), 5.36 (1H, d,
J = 11.5 Hz), 5.04 (1H, d, J = 17.0 Hz), 4.99 (1H, d, J = 10.0 Hz), 4.58 (1H, m), 3.78 (1H, s,
OH), 3.40 (1H, quintet, J = 7.0 Hz), 3.01 (1H, quintet, J = 7.0 Hz,), 2.55 (1H, dd, J = 7.0,
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17.5 Hz), 2.47 (1H, dd, J = 3.5, 17.5 Hz), 2.37-2.33 (2H, m); C 171.6, 136.4, 135.6, 118.3,
116.2, 90.3, 73.7, 39.1, 35.7, 33.4.
(5S,6S)-5-(Benzyloxy)-1-(but-3-en-1-yl)-6-hydroxy-6-vinylpiperidin-2-one (10c). The title
compound was prepared in an analogous fashion to 10b described above, from 9c (0.350 g,
1.28 mmol), THF (15 mL) and vinylmagnesium bromide (1.0 M in THF, 1.92 mmol). The
crude product was purified by column chromatography (1:1, EtOAc/petrol) yielding the title
+ 48.9 (c 4.1 CHCl3). vmax/cm-1 3293, 1634,

compound (0.215 g, 56%) as a colorless oil.

1452, 1398, 1080, 989, 759, 721. H 7.37-7.32 (5H, m), 5.79-5.72 (2H, m), 5.38 (1H, d, J =
17.5 Hz), 5.36 (1H, d, J = 10.5 Hz), 4.99 (1H, d, J = 17.0 Hz), 4.93 (1H, d, J = 10.0 Hz), 4.67
(1H, d, J = 12.0 Hz), 4.51 (1H, d, J = 12.0 Hz), 4.01 (1H, s, OH), 3.62-3.56 (2H, m), 3.073.01 (1H, m), 2.60-2.54 (1H, m), 2.41-2.37 (1H, m), 2.31-2.28 (2H, m), 2.02-1.96 (1H, m),
1.91-1.86 (1H, m). C 169.5, 137.8, 136.8, 136.0, 128.4, 128.0, 127.5, 118.7, 115.7, 87.4,
76.3, 71.3, 41.9, 33.4, 26.6 19.0. HRMS (ESI) m/z calcd for C18H24NO3 [M + H]+ 302.1730,
found 302.1735.
(1S,8aS)-1,8a-Dihydroxy-1,5,6,8a-tetrahydroindolizin-3(2H)-one (3b). To a solution of the
diene 10b (0.100 g, 0.50 mmol) in CH2Cl2 (10 mL) under an atmosphere of nitrogen was
added Grubbs’ 2nd generation catalyst (0.008 g, 0.01 mmol). The reaction mixture was stirred
at rt for 2 h and then concentrated in vacuo. Column chromatography (1:49 MeOH/EtOAc) of
the crude product mixture afforded the title compound (0.059 g, 70%) as a yellow oil.

+

46.5 (c 0.8 CHCl3). vmax/cm-1 3356, 1669, 1362, 1023, 1072, 700. H (300 MHz) 6.07-5.95
(1H, m), 5.84 (1H, d, J = 10.2 Hz), 4.13 (2H, m), 3.15 (1H, dd, J = 4.5, 16.0 Hz), 2.65 (1H,
dd, J = 16.0, 7.5 Hz), 2.44 (1H, dd, J = 16.0, 7.5 Hz), 2.17-2.05 (2H, m). C (75 MHz) 171.1,
128.7, 126.9, 83.7, 70.8, 38.5, 33.2, 24.1. HRMS (ESI) m/z calcd for C8H12NO3 [M + H]+
170.0721, found 170.0723.
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(1S,9aS)-1-(Benzyloxy)-9a-hydroxy-1,2,3,6,7,9a-hexahydro-4H-quinolizin-4-one (3c). The
title compound was prepared in an analogous fashion to 3b described above, from the diene
10c (0.150 g, 0.49 mmol), CH2Cl2 (10 mL) and Grubbs’ 2nd generation catalyst (0.012 g, 0.01
mmol). The reaction mixture was stirred at rt for 1 h and then concentrated in vacuo. The
crude product was purified by column chromatography (2:1 EtOAc/petrol) yielding the title
compound (0.092 g, 68%) as a pale yellow oil.

+ 48.9 (c 4.1 CHCl3). vmax/cm-1 3357,

1662, 1371, 1080, 1024, 989, 759, 702. H 7.31-7.25 (5H, m), 5.94-5.91 (1H, m),5.85 (1H, d,
J = 10.0 Hz), 4.65 (1H, d, J = 12.0 Hz), 4.53 (1H, dd, J = 6.0, 13.0 Hz), 4.49 (1H, d, J = 12.0
Hz), 3.45 (1H, dd, J = 3.5, 10.0 Hz), 3.33 (1H, s, OH), 3.00 (1H, ddd, J = 6.0, 13.0 Hz), 2.56
(1H, dt, J = 5.5, 17.5 Hz), 2.28-2.21 (1H, m), 2.16-2.08 (1H, m), 2.07-2.00 (1H, m), 1.961.91 (1H, m), 1.88-1.83 (1H, m). C 169.7, 137.1, 129.6, 128.5, 128.2, 128.1, 127.9, 80.9,
77.5, 71.7, 34.6, 29.2, 24.6, 20.3. HRMS (ESI) m/z calcd for C16H20NO3 [M + H]+ 274.1482,
found 274.1487.
(1S,9aS)-1-(Benzyloxy)-9a-hydroxy-1,2,5,6,7,9a-hexahydro-3H-pyrrolo[1,2-a]azepin-3-one
(3d). The title compound was prepared in an analogous fashion to 3b described above, from
the diene 10d5 (0.340 g, 1.12 mmol), CH2Cl2 (20 mL) and Grubbs’ 2nd generation catalyst
(0.028 g, 0.03 mmol). The reaction mixture was stirred at rt for 2 h and then concentrated in
vacuo. Column chromatography (2:1 EtOAc/petrol to EtOAc, silica gel was neutralized first
with ammonia) of the crude reaction mixture afforded the title compound (0.273 g, 89%) as a
brown oil. This compound was prone to dehydration to give diene 11 upon storage.

+

33.8 (c 0.7 CHCl3). vmax/cm-1 3356, 1669, 1363, 1073, 1023, 699. H 7.37 – 7.28 (5H, m),
5.99 – 5.94 (1H, m), 5.91 (1H, d, J = 11.9 Hz), 4.68 (1H, d, J = 12.0 Hz), 4.62 – 4.57 (2H,
m), 3.99 (1H, t, J = 5.5 Hz), 3.94 (1H, dd, J = 13.0, 6.5 Hz), 3.17 – 3.09 (1H, m), 2.67 (1H,
dd, J = 16.5, 7.0 Hz), 2.30 (1H, dd, J = 16.5, 5.5 Hz), 2.18 (1H, m), 1.83 (2H, m); C 171.3,
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137.5, 133.8, 128.4, 128.3, 127.8, 127.5, 93.1, 81.4, 72.3, 37.4, 36.2, 26.0, 25.5. HRMS (ESI)
m/z calcd for C16H20NO3 [M + H]+ 274.1456, found 274.1458.
(1S,8aS)-8a-Hydroxy-1-((triisopropylsilyl)oxy)-1,5,6,8a-tetrahydroindolizin-3(2H)-one (3e).
Compound 3b (0.132 g, 0.78 mmol) was dissolved in CH2Cl2 (10 mL) and was treated with
TIPSOTf (0.361 g, 1.18 mmol) and 2,6-lutidine (0.200 g, 1.18 mmol) at 0 oC. The ice bath
was then removed and the reaction mixture was stirred at rt for 30 min. A saturated aqueous
solution of NaHCO3 (10 mL) was added and the aqueous layer was extracted with CH2Cl2
(2x10 mL). The combined organic layers were dried (MgSO4) and concentrated in vacuo. The
crude product was purified by column chromatography (1:5 EtOAc/petrol) yielding the title
+ 14.2 (c 0.2 CHCl3). vmax/cm-1 3296, 1702,

compound (0.306 g, 80%) as a colorless oil.

1357, 1023, 1014, 692. H 5.96 (1H, m), 5.84 (1H, d, J = 10.0 Hz), 4.27 (1H, t, J = 7.5 Hz),
4.15 (2H, m), 3.10 (1H, td, J = 12.0, 5.0 Hz), 2.67 (1H, dd, J = 16.0, 7.5 Hz), 2.54 (1H, dd, J
= 16.0, 7.5 Hz), 2.22 – 2.13 (1H, m), 2.10 – 2.05 (1H, m), 1.07 (21H, s). C 169.9, 128.1,
127.9, 83.6, 71.5, 39.4, 33.5, 23.9, 17.7, 11.6. HRMS (ESI) m/z calcd for C17H32NO3Si [M +
H]+ 326.2136, found 326.2139.
(1S,8aS)-8a-Hydroxy-3-oxo-1,2,3,5,6,8a-hexahydroindolizin-1-yl acetate (3f). To a solution
of diol 3b (0.104 g, 0.60 mmol) in pyridine (10 mL) was added Ac2O (0.080 g, 0.80 mmol) at
rt and the resulting solution was stirred at rt for 16 h. CH2Cl2 (10 mL) and CuSO4 (10 mL,
saturated aqueous solution) were added and the organic layer washed with CuSO4 (3x10 mL)
and then with brine (2x10 mL). The organic layer was dried (MgSO4) and concentrated in
vacuo. Column chromatography (EtOAc) of the crude product gave the title compound
(0.106 g, 84%) as a colorless oil.

+ 32.4 (c 0.2 CHCl3). vmax/cm-1 3365, 2980, 1745,

1653, 1350, 1021, 697. H 5.99 (2H, broad s), 5.11 (1H, t, J = 8.0 Hz), 4.16 (1H, dd, J = 13.0,
6.5 Hz), 3.14 – 3.07 (1H, m), 2.80 (1H, dd, J = 16.8, 8.0 Hz), 2.66 (1H, dd, J = 16.8, 7.5 Hz),
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2.17 (3H, s), 2.15-2.07 (2H, m). C 171.0, 169.7, 129.3, 127.3, 84.1, 71.4, 35.6, 33.2, 23.95,
21.0. LRMS (ESI) m/z 212 [M + H]+
Synthesis of N-acyliminium ion precursors 13-15.
(S)-1-(Benzyloxy)-1,2,5,6-tetrahydro-3H-pyrrolo[1,2-a]azepin-3-one (11). To a solution of
the diene 10b5 (0.500 g, 1.66 mmol) in CH2Cl2 (30 mL) under an atmosphere of nitrogen was
added Grubbs’ 1st generation catalyst (0.040 g, 0.04 mmol). The resulting mixture was stirred
at rt for 2 h and then treated with p-toluenesulfonic acid monohydrate (0.030 g, 0.16 mmol)
for 30 min at rt. The reaction mixture was concentrated in vacuo and subjected to column
chromatography (1:2 EtOAc/petrol) to afford the title compound (0.343 g, 81%) as a light
brown oil.

+ 22.9 (c 0.5 CHCl3). vmax/cm-1 1695, 1407, 1338, 1108, 919, 740, 692. H δ

7.37 – 7.28 (5H, m), 5.92 – 5.81 (2H, m), 5.33 (1H, d, J = 7.0 Hz), 4.60 (2H, app. q, J = 12.0
Hz), 4.50 (1H, d, J = 5.0 Hz), 3.86 (1H, dd, J = 12.0, 6.5 Hz), 3.56 (1H, dd, J = 12.0, 8.0 Hz),
2.72 (1H, dd, J = 17.5, 5.0 Hz), 2.57 (1H, dd, J = 17.5, 2.0 Hz), 2.50 (1H, t, J = 6.5 Hz), 2.44
– 2.38 (1H, m). C 172.6, 142.8, 137.5, 130.6, 128.6, 127.9, 127.8, 124.1, 102.8, 73.2, 70.6 ,
41.0, 37.5, 30.4. HRMS (ESI) m/z calcd for C16H18NO2 [M + H]+ 256.1387, found 256.1388.
Synthesis of 13 and 14 via the endoperoxide 12 (Scheme 4). A two-necked round bottom
flask equipped with a condenser was charged with diene 11 (0.300 g, 1.15 mmol), mesotetraphenylporphyrin (0.021 g, 0.03 mmol) and CH2Cl2 (30 mL). The mixture was radiated
with a 500 W flood light while bubbling O2 gas through the reaction solution. After 2 h TLC
analysis indicated the total consumption of the diene to the endoperoxide. At this stage a
small amount of the reaction mixture was taken then concentrated and subjected to column
chromatography (1:1 EtOAc/petrol) to obtain a pure sample of the endoperoxide 12. Thiourea
(0.087 g, 1.15 mmol) was added to the remaining solution and the mixture was stirred at rt for
18 h. The reaction mixture was concentrated in vacuo and subjected to column
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chromatography (1:49 MeOH/EtOAc) to afford the diol 14 (0.114 g, 41%) and ketone 13
(0.093 g, 28%) both as a colorless oils. Endoperoxide (12):

+ 32.8 (c 0.4 CHCl3).

vmax/cm-1 1717, 1669, 1370, 1091, 1073, 735, 697. H 7.47 – 7.26 (5H, m), 6.72 – 6.67 (1H,
m), 6.64 (1H, d, J = 9.4 Hz), 4.87 (1H, t, J = 6.0 Hz), 4.62 (1H, d, J = 11.6 Hz), 4.55 (1H, d, J
= 11.6 Hz), 4.05 (1H, dd, J = 12.4, 6.0 Hz), 2.82 (1H, dd, J = 17.5, 6.4 Hz), 2.70 (1H, td, J =
13.2, 4.7 Hz), 2.47 (1H, d, J = 17.5 Hz), 2.38 – 2.31 (1H, m), 2.09 (1H, dt, J = 15.1, 5.2 Hz).
C 171.9, 136.7, 130.3, 128.7, 128.3, 127.9, 123.3, 96.6, 76.5, 75.0, 72.3, 36.6, 34.1, 34.1.
HRMS (ESI) m/z calcd for C16H17NO4Na [M + Na]+ 310.2147, found 310.2148. Ketone
(13):

+ 17.3 (c 0.4 CHCl3). vmax/cm-1 3446, 1688, 1398, 1345, 1187, 1115, 907. H 7.40-

7.26 (5H, m), 6.43 (1H, d, J = 13.0 Hz), 6.07 (1H, d, J = 13.0 Hz), 4.61 (1H, d, J = 12.0 Hz),
4.51 (1H, d, J = 12.0 Hz), 4.09 – 4.07 (1H, m), 3.98 – 3.92 (1H, m), 3.48 – 3.35 (1H, m), 2.89
– 2.71 (3H, m), 2.44 (1H, d, J = 17.0 Hz). C 200.6, 172.6, 139.6, 137.0, 131.3, 128.7, 128.2,
127.8, 93.2, 80.0, 71.9, 43.4, 35.6, 33.2. LRMS (ESI) m/z 288 [M + H]+. Diol (14):

+

52.6 (c 0.9 CHCl3). vmax/cm-1 3446, 1689, 1403, 1347, 1191, 1117, 911. H 7.41 – 7.27 (5H,
m), 6.24 (1H, d, J = 12.0 Hz), 6.08 (1H, dd, J = 12.0, 5.5 Hz), 4.70 (1H, d, J = 12.0 Hz), 4.61
(1H, d, J = 12.0 Hz), 4.48 (1H, d, J = 12.0, 5.5 Hz), 4.06 – 3.98 (2H, m), 3.43 – 3.37 (1H, m),
2.67 (1H, dd, J = 16.5, 7.5 Hz), 2.33 (1H, dd, J = 16.5, 7.5 Hz), 1.96 (2H, d, J = 5.0 Hz). C
170.3, 137.5, 136.6, 130.6, 128.6, 128.0, 127.8, 91.5, 80.5, 72.5, 66.8, 36.2, 33.6, 33.0.
HRMS (ESI) m/z calcd for C16H20NO4 [M + H]+ 290.1362, found 290.1367. Key NOESY
correlation for 14: H9 (6.24 ppm) to CH2Ph (4.70 ppm).
(1S,7S,9aS)-1-(Benzyloxy)-7,9a-dihydroxy-1,2,5,6,7,9a-hexahydro-3H-pyrrolo[1,2-a]azepin3-one (15). The enone 13 (0.050 g, 0.17 mmol) was dissolved in MeOH (2 mL) and treated
with NaBH4 (0.032 g, 0.87 mmol) at 0 oC for 3 h. A saturated aqueous solution of NaHCO3
(2 mL) was added and the aqueous layer was extracted with CH2Cl2 (2x3 mL). The combined
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organic layers were dried (MgSO4) and concentrated in vacuo. The crude product was
purified by column chromatography (1:49 MeOH/EtOAc) yielding the title compound (0.034
g, 70%) as a colorless oil.

+ 10.8 (c 0.2 CHCl3). vmax/cm-1 3460, 1675, 1387, 1345,

1201, 1190, 912. H 7.36 – 7.25 (5H, m), 6.02 – 5.97 (2H, m), 4.62 – 4.59 (2H, m), 4.57 (1H,
d, J = 12.0 Hz), 4.48 – 4.41 (1H, m), 3.94 (1H, m), 3.19 – 3.11 (1H, m), 2.65 (1H, dd, J =
17.0, 9.0 Hz), 2.29 (1H, dd, J = 17.0, 5.0 Hz), 1.94 – 1.88 (2H, m). C 171.3, 136.7, 135.8,
130.3, 128.8, 128.1, 127.5, 90.4, 78.9, 71.6, 66.4, 36.6, 33.7, 33.1. HRMS (ESI) m/z calcd for
C16H20NO4 [M + H]+ 290.1362, found 290.1366.
Synthesis of bridged tricyclics 5a-c−8a-c and 17a-c and 18a-c.
(1S,7R,10aS)-1-(Benzyloxy)-7,8,9,10-tetrahydro-1H-7,10a-methanopyrrolo[1,2-a]azocin3(2H)-one

(5a)

and

(1S,7S,10aR)-1-(benzyloxy)-7,8,9,10-tetrahydro-1H-7,10a-

methanopyrrolo[1,2-a]azocin-3(2H)-one (6a). To a solution of 3a (0.150 g, 0.578 mmol) and
allyltrimethylsilane (0.079 g, 0.694 mmol) in CH2Cl2 (6 mL) was added BF3•Et2O (0.164 g,
1.156 mmol) dropwise at 0 oC. The reaction mixture was stirred at rt for 18 h and quenched
with saturated NaHCO3 solution (5 mL). The aqueous layer was extracted with CH2Cl2 (3x5
mL) and the combined organic layers was dried (MgSO4) and then concentrated in vacuo.
Column chromatography (1:1 EtOAc/petrol) of the crude reaction mixture gave a 1:1 mixture
of the title compounds (0.111 g, 68%) as a colorless oil A small amount of each isomer could
be obtained in pure form by further separation by column chromatography. 5a:

- 9.3 (c

6.3 CHCl3). vmax/cm-1 2930, 1684, 1638, 1405, 1369, 1070, 738, 697. H 7.35-7.28 (5H, m),
7.04 (1H, d, J = 8.0 Hz), 5.06 (1H, t, J = 8.0 Hz), 4.58 (1H, d, J = 12.0 Hz), 4.43 (1H, d, J =
12.0 Hz), 3.71 (1H, d, J = 5.0 Hz), 2.73 (1H, dd, J = 5.0, 17.5 Hz), 2.63-2.62 (1H, m), 2.46
(1H, d, J = 17.5 Hz), 2.10 (1H, d, J = 12 Hz), 1.66-1.63 (1H, m), 1.61-1.52 (5H, m), 1.44
(1H, d, J = 12.0 Hz). C 169.4, 137.8, 128.4, 127.7, 127.3, 123.4, 110.9, 79.2, 71.1, 63.9,
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37.5, 36.3, 30.1, 29.7, 29.4, 18.2. LRMS (ESI) m/z [M + H]+ 284. 6a:

+ 91.1 (c 4.2

CHCl3). vmax/cm-1 2926, 1696, 1636, 1401, 1331, 1097, 734, 697. H (300 MHz) 7.39-7.30
(5H, m), 7.03 (1H, d, J = 7.0 Hz), 5.06 (1H, t, J = 7.0 Hz), 4.58 (2H, s), 3.81 (1H, t, J = 9.0
Hz), 2.57 (1H, s), 2.55 (2H, m), 2.04 (1H, d, J = 12.0 Hz), 1.77-1.72 (2H, m), 1.64-1.56 (4H,
m), 1.43 (1H, d, J = 12.0 Hz). C 166.6, 138.3, 128.0, 127.9, 127.7, 123.3, 109.5, 80.9, 71.8,
60.9, 35.4, 35.2, 31.6, 30.2, 29.9, 18.3. HRMS (ESI) m/z calcd for C18H22NO2 [M + H]+
284.1647, found 284.1639. Key NOESY correlation for 6a: H1 (3.81 ppm) to H11 (1.43
ppm). Compounds 5a and 6a had spectroscopic data identical to those reported earlier.5
(1S,7R,10aS)-1-((Triisopropylsilyl)oxy)-1,2,7,8,910-hexahydro-3H-7,10amethanopyrrolo[1,2-a]azocin-3-one

(5b)

and

(1S,7S,10aR)-1-((triisopropylsilyl)oxy)-

1,2,7,8,910-hexahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one (6b). Prepared in a
similar fashion to 5a/6a above, from 3e (0.100 g, 0.30 mmol), allyltrimethylsilane (0.042 g,
0.36 mmol), CH2Cl2 (4 mL) and BF3•Et2O (0.086 g, 0.61 mmol). Column chromatography
(1:3 EtOAc/petrol) of the crude product gave a 1:1 mixture of the title compound (0.081 g,
78%) as a colorless oil. A small amount of each isomer could be obtained in pure form by
further separation by column chromatography. 5b:

- 13.6 (c 0.6 CHCl3). vmax/cm-1 2980,

1653, 1350, 1021, 697. H 7.05 (1H, d, J = 7.0 Hz), 5.06 (1H, t, J = 7.0 Hz), 4.14 (1H, d, J =
9.0 Hz), 2.55 (1H, s), 2.54 (2H, d, J = 9.0 Hz), 2.01 (1H, d, J = 12.0 Hz), 1.71 (1H, s), 1.55
(5H, s), 1.73 (21H, s). C 168.2, 123.0, 111.5, 75.6, 62.7, 39.0, 35.4, 31.1, 30.3, 29.8, 18.3,
18.1, 12.3. LRMS (ESI) m/z 350 [M + H]+. 6b:

+ 83.4 (c 0.7 CHCl3). vmax/cm-1 2917,

1645, 1357, 1071, 692. H 7.06 (1H, d, J = 7.0 Hz), 5.06 (1H, t, J = 7.0 Hz), 4.12 (1H, t, J =
4.5 Hz), 2.84 (1H, dd, J = 17.0, 4.5 Hz), 2.63 (1H, s), 2.27 (1H, d, J = 17.0 Hz), 2.00 (1H, d,
J = 12.0 Hz), 1.65 (1H, d, J = 12.0 Hz), 1.57 (5H, m), 1.42 (1H, d, J = 12.0 Hz), 1.07 (21H,
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s); C 169.7, 123.7, 110.9, 73.9, 64.8, 40.8, 37.4, 30.4, 30.2, 29.8, 18.5, 18.2, 12.5. LRMS
(ESI) m/z 350 [M + H]+.
(1S,7R,10aS)-3-Oxo-2,3,7,8,9,10-hexahydro-1H-7,10a-methanopyrrolo[1,2-a]azocin-1-yl
acetate (5c) and (1S,7S,10aR)-3-oxo-2,3,7,8,9,10-hexahydro-1H-7,10a-methanopyrrolo[1,2a]azocin-1-yl acetate (6c). Prepared in a similar fashion to 5a/6a above, from 3f (0.100 g,
0.30 mmol), allyltrimethylsilane (0.042 g, 0.36 mmol), CH2Cl2 (4 mL) and BF3•Et2O (0.086
g, 0.61 mmol). Column chromatography (1:3 EtOAc/petrol) of the crude product gave a 1:1
mixture of the title compounds (0.081 g, 78%) as a colorless oil. A small amount of each
isomer could be obtained in pure form by further separation by column chromatography. 5c:
-17.4 (c 0.6 CHCl3). vmax/cm-1 2922, 1706, 1692, 1352, 1028, 1004, 642. H 6.99 (1H, d,
J = 7.5 Hz), 5.02 (1H, t, J = 7.5 Hz), 4.93 (1H, d, J = 8.0 Hz), 2.69 (1H, dd, J = 16.5, 8.0 Hz),
2.54-2.50 (2H, m), 2.05 (3H, s), 1.91 (1H, d, J = 12.0 Hz), 1.70 (1H, d, J = 12.0 Hz), 1.58 –
1.43 (6H, m). C 170.4, 167.1, 122.9, 111.5, 74.9, 61.3, 35.3, 35.2, 32.1, 29.8, 29.7, 21.0,
18.2. HRMS (ESI) m/z calcd for C13H17NO3Na [M + Na]+ 258.1106, found 258.1119. 6c:
+72.8 (c 0.2 CHCl3). H 7.07 (1H, d, J = 8.0 Hz), 5.14-5.10 (2H, m,), 2.94 (1H, dd, J =
18.0, 5.5 Hz), 2.64 (1H, s), 2.34 (1H, d, J = 18.0 Hz), 2.08 (3H, s), 1.73 (1H, d, J = 11.5 Hz),
1.66 – 1.57 (7H, m). C 170.5, 168.2, 123.5, 111.2, 74.0, 63.1, 37.0, 36.9, 30.0, 29.6, 29.4,
20.9, 18.2. HRMS (ESI) m/z calcd for C13H17NO3Na [M + Na]+ 258.1106, found 258.1118.
(1S,7R)- and (1S,7S)-7-Allyl-1-(benzyloxy)-1,5,6,7-tetrahydroindolizin-3(2H)-one (16). To a
solution of 3a (0.050 g, 0.19 mmol) and allyltributyltin (0.075 g, 0.23 mmol) in CH2Cl2 (2
mL) was added BF3•Et2O (0.053 g, 0.38 mmol) dropwise at 0 oC. The reaction mixture was
stirred at rt for 18 h and quenched with saturated NaHCO3 solution (5 mL). The aqueous
layer was extracted with CH2Cl2 (3x5 mL) and the combined organic layers were dried
(MgSO4) and then concentrated in vacuo. Column chromatography (1:2 EtOAc/petrol) of the
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crude product gave a 1:1 mixture of the title compounds (0.039 g, 72%) as a colorless oil. A
small amount of each isomer could be obtained in pure form by further separation by column
chromatography. (1S,7R)-16 could be converted to 5a and (1S,7S)-16 to 6a upon treatment
with BF3•Et2O. (1S,7R)-16:

+ 31.5 (c 0.2 CHCl3). vmax/cm-1 2928, 1717, 1669, 1370,

1091, 1070, 735, 697. H 7.37-7.25 (5H, m), 5.83-5.78 (1H, m), 5.10-5.007 (3H, m), 4.59
(2H, app. q, J = 11.5 Hz), 4.52 (1H, d, J = 6.5 Hz), 3.72-3.67 (1H, m), 3.40-3.35 (1H, m),
2.68 (1H, dd, J = 6.5, 17.0 Hz), 2.51 (1H, d, J = 17.0 Hz), 2.36 (1H, br. s), 2.19-2.11 (2H, m),
1.87-1.83 (1H, m), 1.58-1.52 (1H, m). C 171.5, 138.7, 137.5, 136.0, 128.5, 127.8, 127.7,
116.7 , 105.9, 71.6, 70.4, 40.1, 37.5, 37.1, 32.1, 26.1. HRMS (ESI) m/z calcd for C18H22NO2
[M + H]+ 284.1645, found 284.1651. (1S,7S)-16:

- 0.5 (c 0.2 CHCl3). vmax/cm-1 2917,

1717, 1671, 1406, 1369, 1088, 1068, 735, 697. H 7.37-7.30 (5H, m), 5.82-5.76 (1H, m,),
5.08-5.00 (3H, m), 4.59 (2H, app. q, J = 12.0 Hz), 4.52 (1H, d, J = 6.5 Hz), 3.81-3.78 (1H,
m), 3.34-3.29 (1H, m), 2.68 (1H, dd, J = 6.5, 17.0 Hz), 2.53 (1H, d, J = 17.0 Hz), 2.41 (1H,
br. s), 2.13 (2H, br. s), 1.93-1.89 (1H, m), 1.43-1.38 (1H, m); C 171.6 , 138.8, 137.5, 135.9 ,
128.5, 127.9, 127.8, 116.8 , 106.0, 71.7, 70.6, 39.9, 37.5, 37.4, 32.1, 26.2. HRMS (ESI) m/z
calcd for C18H21NO2Na [M + Na]+ 306.1478, found 306.1470.
(1S,7R,9R,10aS)-1-(Benzyloxy)-9-methyl-7,8,9,10-tetrahydro-1H-7,10amethanopyrrolo[1,2a]azocin-3(2H)-one (7a) and (1S,7S,9S,10aR)-1-(benzyloxy)-9-methyl7,8,9,10-tetrahydro-1H-7,10a-methanopyrrolo[1,2a]azocin-3(2H)-one

(8a).

The

title

compounds were prepared in a similar fashion to 5a/6a above, from 3a (0.120 g, 0.463
mmol), metallyltrimethylsilane (0.071 g, 0.555 mmol), CH2Cl2 (5 mL) and BF3•Et2O (0.131
g, 0.926 mmol). Column chromatography (1:1 EtOAc/petrol) of the crude product gave a 1:1
mixture of the title compounds (0.104 g, 76%) as a colorless oil A small amount of each
isomer could be obtained in pure form by further separation by column chromatography. 7a:
- 1.6 (c 0.3 CHCl3). vmax/cm-1 2922, 1680, 1600, 1435, 1377, 1071, 749, 683.H 7.3640

7.29 (5H, m), 6.99 (1H, d, J = 7.5 Hz), 5.11 (1H, t, J = 7.5 Hz), 4.60 (1H, d, J = 12.0 Hz),
4.44 (1H, d, J = 12.0 Hz), 3.73 (1H, d, J = 5.0 Hz), 2.75 (1H, dd, J = 5.0, 17.5 Hz), 2.61 (1H,
br s), 2.48 (1H, d, J = 17.5 Hz), 2.10 (1H, d, J = 13.0 Hz), 1.82-1.79 (1H, m), 1.67 (2H, br s),
1.60 (1H, d, J = 13.0 Hz), 1.26-1.17 (1H, m), 1.10 (1H, t, J = 13.0 Hz), 0.86 (3H, d, J = 6.5
Hz). C 169.5, 137.9, 128.5, 127.8, 127.5, 123.1, 111.9, 79.2, 71.1, 64.5, 46.2, 39.3, 36.3,
29.7, 29.5, 24.7, 21.5. LRMS (ESI) m/z [M + H]+ 298. 8a:

+ 67.5 (c 0.3 CHCl3).

vmax/cm-1 2928, 1677, 1415, 1349, 1079, 768, 698. H 7.38-7.30 (5H, m), 6.97 (1H, d, J = 8.0
Hz), 5.09 (1H, t, J = 8.0 Hz), 4.61 (1H, d, J = 12.0 Hz), 4.57 (1H, d, J = 12.0 Hz), 3.83 (1H, t,
J = 9.0 Hz), 2.56 (2H, d, J = 17.0 Hz), 2.53 (1H, br s), 1.95 (1H, d, J = 12.0 Hz), 1.81-1.76
(2H, m), 1.63 (1H, d, J = 13.0 Hz), 1.42 (1H, d, J = 12.0 Hz), 1.38 (1H, t, J = 13.0 Hz), 1.89
(1H, dt, J = 3.0, 13.0 Hz), 0.92 (3H, d, J = 6.0 Hz). C 167.7, 137.6, 128.4, 127.9, 127.5,
122.3, 111.9, 80.6, 72.3, 62.0, 40.0, 39.0, 35.6, 35.2, 29.8, 24.6, 21.7. HRMS (ESI) m/z calcd
for C19H24NO2 [M + H]+ 298.1776, found 298.1789. Key NOESY correlations for 8a: H1
(3.81 ppm) to H11 (1.42 ppm) and CH3 (0.92 ppm) to H11 (1.95 ppm and 1.42 ppm).
Compounds 7a and 8a had spectroscopic data identical to those reported earlier.5
(1S,7R,9R,10aS)-1-(Benzyloxy)-9-phenyl-1,2,7,8,9,10-hexahydro-3H-7,10amethanopyrrolo[1,2-a]azocin-3-one

(7b)

and

(1S,7R,9R,10aS)-1-(benzyloxy)-9-phenyl-

1,2,7,8,9,10-hexahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one

(8b)

and

(1S)-1-

(benzyloxy)-9-phenyl-1,2,7,10-tetraahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one
(19). The title compounds were prepared in a similar fashion to 5a/6a above, from 3a (0.050
g, 0.19 mmol), trimethyl(2-phenylallyl)silane[3] (0.044 g, 0.23 mmol), CH2Cl2 (2 mL) and
BF3•Et2O (0.053 g, 0.38 mmol). Column chromatography (1:2 EtOAc/petrol) of the crude
product gave a 7:3 mixture of 7b and 8b, respectively (0.041 g, 61%) as a colorless oil and
compound 19 (0.007 g, 5%, ca 80% pure) as a colorless oil. A small amount of 7b could be
obtained in pure form by further separation by column chromatography. 7b:
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+ 34.1 (c

0.3 CHCl3). vmax/cm-1 2928, 1675, 1415, 1347, 1072, 763, 692. H 7.37-7.54 (10H, m), 7.09
(1H, d, J = 8.5 Hz), 4.82 (1H, t, J = 8.5 Hz), 4.62 (1H, d, J = 12.0 Hz), 4.45 (1H, d, J = 12.0
Hz), 3.81 (1H, d, J = 5.0 Hz), 2.94 (1H, d, J = 12.5 Hz), 2.80 (1H, dd, J = 5.0, 17.5 Hz), 2.73
(1H, s), 2.52 (1H, d, J = 17.5 Hz), 2.25 (1H, d, J = 12.5 Hz), 2.01-1.98 (1H, m), 1.90-1.85
(2H, m), 1.73 (1H, J= 12.5 Hz, 1.67-1.59 (1H, m). C 169.5, 143.8, 137.6, 128.7, 128.4,
128.2, 127.7, 127.5, 127.3, 126.9, 126.3, 125.6, 123.9, 107.9, 79.0, 71.0, 63.3, 47.4, 37.9,
36.5, 36.4, 30.9, 23.3. HRMS (ESI) m/z calcd for C24H26NO2 [M + H]+ 360.1983, found
360.1986. 19:

+ 20.1 (c 0.1 CHCl3). vmax/cm-1 2932, 1647, 1417, 1338, 1091, 743, 618.

H 7.40-7.31 (10H, m), 6.21 (1H, s), 4.63 (1H, d, J = 12.0 Hz), 4.49 (1H, d, J = 12.0 Hz),
4.02 (1H, d, J = 12.5 Hz), 3.88 (1H, t, J = 4.5 Hz), 2.95 (1H, t, J = 12.5 Hz), 2.89 (1H, s),
2.76-2.68 (2H, m), 2.50-2.44 (2H, m), 1.97 (1H, d, J = 13.0 Hz), 1.85 (1H, d, J = 13.0 Hz),
1.71 (1H, J = 12.5 Hz), 1.57 (1H, t, J = 12.5 Hz). C 170.5, 140.0, 137.7, 137.0, 128.8, 128.4,
127.8, 127.5, 127.4, 126.4, 125.3, 125.0, 79.1, 71.9, 39.6, 36.4, 35.0, 30.6, 29.8, 27.9. LRMS
(ESI) m/z ([M + H]+) 360.
(1S,7R,9R,10aS)-1-(Benzyloxy)-9-(chloromethyl)-1,2,7,8,9,10-hexahydro-3H-7,10amethanopyrrolo[1,2-a]azocin-3-one

(7c)

and

(1S,7S,9S,10aR)-1-(benzyloxy)-9-

(chloromethyl)-1,2,7,8,9,10-hexahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one

(8c).

The title compounds were prepared in a similar fashion to 5a/6a above, from 3a (0.050 g,
0.23 mmol), (2-(chloromethyl)allyl)trimethylsilane (0.032 g, 0.28 mmol), toluene (2 mL) and
BF3•Et2O (0.066 g, 0.47 mmol). The reaction mixture was heated at 70 oC for 18 h. Column
chromatography (1:1.5 EtOAc/petrol) of the crude product gave a 1:1 mixture of the title
compounds (0.038 g, 70%) as a colorless oil. A small amount of each isomer could be
obtained in pure form by further separation by column chromatography. 7c:

- 13.4 (c

0.2 CHCl3). vmax/cm-1 2954, 1680, 1367, 1033, 1014, 704. H 7.38 – 7.24 (5H, m), 7.01 (1H,
d, J = 7.0 Hz), 5.12 (1H, t, J = 7.0 Hz), 4.60 (1H, d, J = 12.0 Hz), 4.44 (1H, d, J = 12.0 Hz),
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3.77 (1H, d, J = 5.0 Hz), 3.45 (1H, dd, J = 10.5, 5.5 Hz), 3.38 (1H, dd, J = 10.5, 5.5 Hz), 2.77
(1H, dd, J = 17.0, 5.0 Hz), 2.69 (1H, br. s), 2.50 (1H, d, J = 17.0 Hz), 2.11 (2H, m), 1.82 (1H,
d, J = 12.5 Hz), 1.73 (1H, d, J = 12.5 Hz), 1.63 (1H, d, J = 12.5 Hz), 1.44 (1H, td, J = 12.5,
3.0 Hz), 1.32 (1H, t, J = 12.0 Hz). C 169.5, 137.7, 128.6, 127.9, 127.5, 123.4, 111.2, 79.1,
71.3, 64.1, 50.2 (CH2Cl), 41.4, 36.4, 34.9, 32.6, 29.6, 29.2. LRMS (ESI) m/z [M + H]+ 332
(35Cl, 100%), 334 (37Cl, 30%). 8c:

+ 94.2 (c 0.8 CHCl3). vmax/cm-1 2922, 1706, 1352,

1028, 1004, 642. H (300 MHz) 7.44 – 7.25 (5H, m), 7.00 (1H, d, J = 8.0 Hz), 5.11 (1H, t, J =
7.1 Hz), 4.60 (2H, q, J = 11.9 Hz), 3.87 (1H, t, J = 9.0 Hz), 3.45 (2H, d, J = 5.8 Hz), 2.58
(3H, m), 2.17 – 2.02 (1H, m), 1.98 (1H, d, J = 12.0 Hz), 1.93 (1H, d, J = 12.0 Hz), 1.78 (1H,
d, J = 12.0 Hz), 1.59 (1H, t, J = 12.0 Hz), 1.45 (1H, d, J = 12.0 Hz), 1.36 (1H, dd, J = 12.0,
3.5 Hz). C (75 MHz, CDCl3) 167.8, 137.5, 128.7, 128.2, 127.7, 122.7, 111.4, 80.4, 72.5,
61.7, 50.4, 35.7, 35.1, 34.7, 32.8, 29.3. HRMS (ESI) m/z calcd for C19H23NO235Cl [M + H]+
332.1412, found 332.1417.
(1S,8R,11aS)-1-(Benzyloxy)-2,3,8,9,10,11-hexahydro-8,11a-methanopyrido[1,2-a]azocin4(1H)-one

(17a)

and

(1S,8R,11aS)-1-(benzyloxy)-2,3,8,9,10,11-hexahydro-8,11a-

methanopyrido[1,2-a]azocin-4(1H)-one (18a). The title compounds were prepared in a
similar fashion to 5a/6a above, from 3c (0.045 g, 0.0.16 mmol), CH2Cl2 (4 mL)
allyltrimethylsilane (0.022 g, 0.19 mmol) and BF3•Et2O (0.046 g, 0.32 mmol) The crude
product was purified by column chromatography (1:1.5 EtOAc/petrol) yielding a 1:1 mixture
of the title compounds (0.042 g, 85%) as a colorless oil. A small amount of each isomer could
be obtained in pure form by further separation by column chromatography. 17a:

-11.3

(c 6.3 CHCl3). vmax/cm-1 2930, 1685, 1639, 1408, 1374, 1066, 739, 692. H 7.57 (1H, d, J =
7.5 Hz), 7.44-7.33 (5H, m), 5.07 (1H, t, J = 7.5 Hz), 4.70 (1H, d, J = 12.0 Hz), 4.48 (1H, d, J
= 12.0 Hz), 3.40 (1H, s), 2.72 – 2.63 (1H, m), 2.56 – 2.48 (2H, m), 2.39 (1H, d, J = 12.8 Hz),
2.11 – 2.02 (2H, d, J = 7.5 Hz), 1.86 (1H, d, J = 13.0 Hz), 1.70 (1H, dt, J = 13.0, 12.0 Hz),
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1.56 (2H, d, J = 12.0 Hz), 1.47 (1H, dt, J = 13.0, 12.0 Hz), 1.36 (1H, d, J = 11.0 Hz), 1.31
(1H, d, J = 13.0 Hz).
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C 167.2, 138.0, 129.4, 128.4, 128.0, 125.7, 111.0, 77.4, 70.8, 58.6

(C11a), 38.2, 32.9, 28.7, 27.7, 27.0, 18.8, 18.0. HRMS (ESI) m/z calcd for C19H24NO2 [M +
H]+ 298.1763, found 298.1767. Key NOESY correlation: H1 (3.40 ppm) to H11 (1.36 ppm).
18a:

+ 73.8 (c 0.5 CHCl3). vmax/cm-1 2922, 1663, 1407, 1331, 1090, 989, 759. H 7.44

(1H, d, J = 7.5 Hz), 7.40 – 7.28 (5H, m), 5.09 (1H, t, J = 7.5 Hz), 4.66 (1H, d, J = 12.5 Hz),
4.54 (1H, d, J = 12.5 Hz), 3.38 (1H, dd, J = 12.0, 4.6 Hz), 2.65 (1H, dd, J = 18.8, 8.3 Hz),
2.57-2.49 (3H, m), 2.19 (1H, d, J = 12.0 Hz), 2.12 – 2.02 (1H, m), 1.96 – 1.85 (1H, m), 1.841.79 (1H, m), 1.71 (1H, d, J = 12.0 Hz), 1.67 – 1.56 (2H, m, 10), 1.52 (2H, br. s), 1.41 (1H, d,
J = 12.0 Hz). C 166.8, 138.3, 128.7, 127.9, 127.6, 125.6, 111.9, 79.5, 71.8, 58.3 (C11a),
34.9, 31.6, 29.3, 29.0, 28.0, 20.4, 17.9. HRMS (ESI) m/z calcd for C19H24NO2 [M + H]+
298.1763, found 298.1769.
(1S,8R,10R,11aS)-1-(Benzyloxy)-10-methyl-2,3,8,9,10,11-hexahydro-8,11amethanopyrido[1,2-a]azocin-4(1H)-one

(17b)

and

(1S,8S,10S,11aR)-1-(benzyloxy)-10-

methyl-2,3,8,9,10,11-hexahydro-8,11a-methanopyrido[1,2-a]azocin-4(1H)-one (18b)
The title compounds were prepared in a similar fashion to 5a/6a above, from 3c (0.045 g,
0.16 mmol), metallyltrimethylsilane (0.025 g, 0.19 mmol), CH2Cl2 (4 mL) and BF3•Et2O
(0.046 g, 0.32 mmol). Column chromatography (1:1.5 EtOAc/petrol) of the crude product
gave a 1:1 mixture of the title compounds (0.041 g, 83%) as a colorless oil. A small amount
of isomer 18b could be obtained in pure form by further separation by column
chromatography. 18b:

+ 62.7 (c 0.1 CHCl3). vmax/cm-1 2928, 1676, 1412, 1354, 1079,

765, 693. H 7.33 (6H, m), 5.14 (1H, t, J = 7.5 Hz), 4.68 (1H, d, J = 12.0 Hz), 4.51 (1H, d, J =
12.0 Hz), 3.41 (1H, dd, J = 12.0, 3.5 Hz), 2.66 (1H, dd, J = 18.5, 8.5 Hz), 2.54 – 2.50 (1H,
m), 2.46 (1H, m), 2.13 (1H, d, J = 12.0 Hz), 2.08 (1H, m), 1.94 (1H, m), 1.83 (1H, m), 1.72
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(1H, t, J = 13.0 Hz), 1.59 (1H, d, J = 13.0 Hz), 1.43 (1H, d, J = 13.0 Hz), 1.14 (2H, m), 0.89
(3H, d, J = 6.0 Hz). C 166.6, 137.5, 128.4, 127.8, 127.7, 124.9, 112.4, 79.3, 71.6, 59.2
(C11a), 40.1, 37.9, 34.4, 29.1, 28.0, 24.1, 21.8, 20.1. HRMS (ESI) m/z calcd for C20H26NO2
[M + H]+ 312.1954, found 312.1956. 17b: (in part from 1H NMR spectrum of the mixture) H
7.47 (1H, d, J = 8.0 Hz), 5.08 (1H, t, J = 8.0 Hz), 4.45 (1H, d, J = 11.9 Hz), 3.37 (1H, s), 0.86
(3H, d, J = 6.3 Hz).
(1S,8R,10R,11aS)-1-(Benzyloxy)-10-phenyl-2,3,8,9,10,11-hexahydro-8,11amethanopyrido[1,2-a]azocin-4(1H)-one

(17c)

and

(1S,8S,10S,11aR)-1-(benzyloxy)-10-

phenyl-2,3,8,9,10,11-hexahydro-8,11a-methanopyrido[1,2-a]azocin-4(1H)-one (18c). The
title compounds were prepared in a similar fashion to 5a/6a above, from 3c (0.050 g, 0.18
mmol), trimethyl(2-phenylallyl)silane11 (0.063 g, 0.18 mmol), CH2Cl2 (2 mL) and BF3•Et2O
(0.051 g, 0.36 mmol). Column chromatography (1:1.5 EtOAc/petrol) of the crude product
gave a 7:3 mixture of the title compounds (0.039 g, 58%), respectively, as a colorless oil. A
small amount of 17c could be obtained pure by further column chromatography. 17c:

-

2.3 (c 0.1 CHCl3). vmax/cm-1 2941, 1678, 1396, 1299, 1103, 761, 687. H 7.51 (1H, d, J = 8.0
Hz), 7.40 – 7.15 (10H, m), 5.22 (1H, t, J = 8.0 Hz), 4.69 (1H, d, J = 11.9 Hz), 4.53 (1H, d, J
= 11.9 Hz), 3.44 (1H, s), 3.10 – 2.99 (1H, m), 2.65 (2H, m), 2.49 (2H, m), 2.07 – 1.97 (2H,
m), 1.93 – 1.86 (1H, m), 1.78 (1H, d, J = 13.5 Hz), 1.74 – 1.66 (1H, m), 1.54 – 1.42 (2H, m).
C 166.8, 145.8, 138.1, 128.6, 128.6, 128.5, 128.0, 127.8, 127.4, 126.4, 112.2, 79.1, 71.8,
58.9, 47.2, 46.3, 39.5, 36.2, 36.1, 34.5, 20.2. HRMS (ESI) m/z 374 [M + H]+. 18c (in part
from 1H NMR spectrum of the mixture) H 7.61 (1H, d, J = 8.0 Hz), 5.17 (1H, t, J = 8.0 Hz),
3.46 (1H, dd, J = 4.7, 11.8 Hz).
Deuterium Labelling Studies
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(S)-1-(But-3-en-1-yl-1,1-d2)-2,5-dioxopyrrolidin-3-yl acetate. The title compound was
prepared in an analogous fashion to its non-deuterated analogue as described earlier.5 L-Malic
acid (0.626 g, 4.671 mmol) was heated at reflux in acetyl chloride (40 mL) for 2 h then the
excess amount of acetyl chloride was evaporated in vacuo to give a colorless oil. A solution
of this oil in CH2Cl2 (10 mL) was treated with a solution of but-3-en-1,1-d2-1amine12 (0.341
g, 4.671 mmol) in CH2Cl2 (10 mL) at 0 oC. The resulting solution was stirred at ambient
temperature for 16 h. The CH2Cl2 was evaporated in vacuo to afford a white solid which was
then heated at reflux with acetyl chloride (40 mL) for 3 h. After evaporation of the excess
amount of acetyl chloride the crude product was subjected to column chromatography (1:1,
EtOAc/petrol) to yield the desired product (0.253 g, 41%) as a light yellow oil.

- 17.3 (c

0.4 CHCl3). vmax/cm-1 3453, 1746, 1679, 1387, 1352, 1191, 1112, 923. H (300 MHz) 5.775.68 (1H, m), 5.43 (1H, dd, J = 5.0, 8.5 Hz), 5.09-5.04 (2H, m), 3.15 (1H, dd, J = 8.5, 18.0
Hz), 2.64 (1H, dd, J = 5.0, 18.0 Hz), 2.36 (2H, d, J = 6.9 Hz), 2.16 (3H, s). C (75 MHz,
CDCl3) 173.3, 173.1 , 169.7 , 133.8 , 117.6 , 67.2, 37.5 (NCD2, quintet, J = 21.7 Hz), 35.1,
31.3, 20.3. LRMS (ESI) m/z [M + H]+ 214.
(S)-1-(But-3-en-1-yl-1,1-d2)-3-hydroxypyrrolidine-2,5-dione.

The

title

compound

was

prepared in an analogous fashion to its non-deuterated analogue as described earlier.5 (S)-1(But-3-en-1-yl-1,1-d2)-2,5-dioxopyrrolidin-3-yl acetate (0.238 g, 1.11 mmol) was dissolved
in EtOH (20 mL) and treated with acetyl chloride (0.325 g, 4.17 mmol) at ambient
temperature for 16 h. The EtOH was evaporated and the crude product was subject to column
chromatography (1:1, EtOAc/petrol) to afford the desired product (0.142 g) as a colorless oil
in 75% yield.

- 72.0 (c 0.3 CHCl3). vmax/cm-1 3443, 1689, 1389, 1342, 1175, 1122, 921.

H 5.73-5.66 (1H, m), 5.07-5.03 (2H, m), 4.66 (1H, dd, J = 5.0, 8.0 Hz), 4.41 (1H, s, OH),
3.07 (1H, dd, J = 8.0, 18.0 Hz), 2.67 (1H, dd, J = 5.0, 18.0 Hz), 2.33 (2H, d, J = 6.5 Hz). C
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178.6, 174.2, 133.8, 117.6, 66.6, 37.3 (NCD2, quintet, J = 21.0 Hz), 37.0, 31.4. LRMS (ESI)
m/z [M + H]+ 172.
(S)-3-(Benzyloxy)-1-(but-3-en-1-yl-1,1-d2)pyrrolidine-2,5-dione. The title compound was
prepared in an analogous fashion to its non-deuterated analogue as described earlier5 in a
similar

manner

to

9c

described

above

from

(S)-1-(but-3-en-1-yl-1,1-d2)-3-

hydroxypyrrolidine-2,5-dione (0.130 g, 0.75 mmol), Et2O (10 mL) BnBr (0.258 g, 1.51
mmol) and Ag2O (0.350 g, 1.51 mmol). Column chromatography (1:4, EtOAc/petrol) of the
crude product gave the desired compound (0.195 g) in 90% yield as a colorless oil.

-

65.0 (c 4.2 CHCl3). vmax/cm-1 1696, 1405, 1329, 1115, 919. H 7.34-7.28 (5H, m), 5.72-5.67
(1H, m), 5.05-5.00 (2H, m), 4.93 (1H, d, J = 12.0 Hz), 4.73 (1H, d, J = 12.0 Hz), 4.29 (1H,
dd, J = 4.5, 8.5 Hz), 2.86 (1H, dd, J = 8.5, 18.0 Hz), 2.59 (1H, dd, J = 4.5, 18.0 Hz), 2.31
(2H, d, J = 6.5 Hz). C 175.8, 174.1, 136.8, 134.1, 128.5, 128.2, 128.1, 117.6, 72.8, 72.1, 36.9
(NCD2, quintet, J = 20.8 Hz), 36.1, 31.6. LRMS (ESI) m/z [M + H]+ 262.
(4S,5S)-4-(Benzyloxy)-1-(but-3-en-1-yl-1,1-d2)-5-hydroxy-5-vinylpyrrolidin-2-one. The title
compound was prepared in an analogous fashion to its non-deuterated analogue as described
earlier5 in a similar manner to 10b described above from (S)-3-(benzyloxy)-1-(but-3-en-1-yl1,1-d2)pyrrolidine-2,5-dione (0.289 g, 0.34 mmol), THF (5 mL) and vinylmagnesium
bromide (0.51 mmol, 1M solution in THF) at 0 oC. After stirring the mixture at 0 oC for 1.5 h,
the reaction mixture was quenched with NH4Cl (5 mL, saturated aqueous solution) After a
similar work up procedure the crude product was purified by column chromatography (1:1,
EtOAc/petrol) yielding the title compound as a colorless oil (74 mg, 76%) and as a mixture of
distereomers (20:80). A small amount of each isomer could be obtained in pure form by
further separation by column chromatography. Major isomer:

+ 45.1 (c 0.9 CHCl3).

vmax/cm-1 3290, 2941, 1670, 1409, 1360, 1077, 919, 738. H 7.34-7.28 (5H, m), 6.05 (1H, dd,
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J = 11.0, 17.5 Hz), 5.80-5.72 (1H, m), 5.60 (1H, d, J = 17.0 Hz), 5.47 (1H, d, J = 11.0 Hz,),
5.07-5.04 (2H, m), 4.62 (1H, d, J = 11.5 Hz), 4.52 (1H, d, J = 11.5 Hz), 3.95 (1H, t, J = 6.5
Hz), 3.53 (1H, s, OH), 2.75 (1H, dd, J = 6.5, 16.5 Hz), 2.38 (1H, dd, J = 4.5, 16.5 Hz), 2.30
(2H, d, J = 6.5 Hz). C 172.0, 137.1, 135.7, 134.9, 128.1, 127.5, 127.3, 117.8, 116.6, 92.5,
81.6, 71.7, 38.1 (NCD2, quintet, J = 20.0 Hz), 36.1, 32.8. LRMS (ESI) m/z [M + H]+ 290.
Minor isomer:

+ 51.9 (c 1.8 CHCl3). vmax/cm-1 3290, 1663, 1418, 1357, 1076, 916, 731.

H 7.37-7.29 (5H, m), 5.78-5.73 (2H, m), 5.51 (1H, d, J = 17.0 Hz), 5.36 (1H, d, J = 10.5 Hz),
5.04 (1H, d, J = 17.5 Hz), 4.99 (1H, d, J = 10.0 Hz), 4.63 (1H, d, J = 11.5 Hz), 4.59 (1H, d, J
= 11.5 Hz), 3.89 (1H, t, J = 6.0 Hz), 3.85 (1H, s, OH), 2.57 (1H, dd, J = 6.0, 16.5 Hz), 2.48
(1H, dd, J = 2.5, 16.5 Hz), 2.33 (2H, d, J = 6.5 Hz,). C 171.4, 137.2, 136.5, 135.5, 128.6,
128.3, 127.8, 118.2, 116.4, 90.2, 77.0, 72.4, 38.8 (NCD2, quintet, J = 20.0 Hz), 35.4, 33.2
(CH2CH=CH2). LRMS (ESI) m/z [M + H]+ 290.
(1S,8aS)-1-(Benzyloxy)-8a-hydroxy-1,5,6,8a-tetrahyroindolizin-3(2H)-one-5,5-d2 (20). The
title compound was prepared in a similar manner to its non-deuterated analogue 3a as
described

above

from

(4S,5S)-4-(benzyloxy)-1-(but-3-en-1-yl-1,1-d2)-5-hydroxy-5-

vinylpyrrolidin-2-one (0.020 g, 0.06 mmol), CH2Cl2 (2 mL) and Grubbs’ 1st generation
catalyst (0.003 g, 3.46x10-3 mmol). After 1 h the CH2Cl2 was evaporated in vaccuo. The
crude product was purified by column chromatography (2:1 EtOAc/petrol) yielding the title
compound (0.015 g, 87%) as a pale yellow oil. H 7.29 – 7.18 (5H, m), 5.98 – 5.91 (1H, m),
5.85 (1H, d, J = 10.0 Hz), 4.51 (1H, d, J = 12.0 Hz), 4.44 (1H, d, J = 12.1 Hz), 3.97 (1H, d, J
= 5.0 Hz), 2.76 (1H, dd, J = 17.0, 5.0 Hz), 2.30 (d, J = 17.0 Hz), 2.17 (1H, d, J = 17.5 Hz),
1.97 (dd, J = 17.5, 5.5 Hz).
(1S,7R,9R,10aS)-1-(Benzyloxy)-9-methyl-1,2,7,8,9,10-hexahydro-3H-7,10amethanopyrrolo[1,2-a]azocin-3-one-5,9-d2 (26) and (1S,7S,9S,10aR)-1-(benzyloxy)-9-methyl-
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1,2,7,8,9,10-hexahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one-5,9-d2 (27). The title
compounds were prepared in a similar manner to their non-deuterated analogues 7a/8a
described above from 20 (0.020 g, 0.07 mmol), methallyltrimethylsilane (0.011 g, 0.09
mmol), CH2Cl2 (2 mL) and BF3•Et2O (0.021 g, 0.15 mmol). Column chromatography (1:1
EtOAc/petrol) gave a 1:1 mixture the title compounds (0.017 g, 75%) as a colorless oil. A
small amount of each isomer could be obtained in pure form by further separation by column
chromatography. 26:

- 19.9 (c 0.3 CHCl3). vmax/cm-1 2929, 1686, 1627, 1405, 1381,

1072, 738, 697. H 7.35-7.26 (5H, m), 5.10 (1H, d, J = 6.0 Hz), 4.59 (1H, d, J = 12.0 Hz),
4.42 (1H, d, J = 12.0 Hz), 3.72 (1H, d, J = 5.0 Hz), 2.75 (1H, dd, J = 5.0, 17.0 Hz), 2.60 (1H,
br. s), 2.46 (1H, d, J = 17.0 Hz), 2.09 (1H, d, J = 12.5 Hz), 1.71-1.58 (3H, m), 1.19 (1H, d, J
= 11.5 Hz), 1.09 (1H, d, J = 11.5 Hz), 0.84 (3H, s, Me). C 169.3, 137.8, 128.4, 127.7, 127.3,
123.0 (t, J = 26.8 Hz), 111.5, 79.2, 71.1, 64.4, 46.1, 39.2, 36.3, 29.7, 29.5, 24.5 (t, J = 19.3
Hz), 21.6. LRMS (ESI) m/z [M + H]+ 300. 27:

+ 44.1 (c 0.2 CHCl3). vmax/cm-1 2921,

1696, 1622, 1390, 1084, 741, 687.H 7.38-7.26 (5H, m), 5.09 (1H, d, J = 6.5 Hz), 4.61 (1H, d,
J = 12.0 Hz), 4.57 (1H, d, J = 12.0 Hz), 3.89 (1H, t, J = 9.0 Hz), 2.56 (2H, d, J = 9.0 Hz),
2.52 (1H, br. s), 1.95 (1H, d, J = 11.5 Hz), 1.79 (1H, d, J = 13.5 Hz), 1.62 (1H, br. s), 1.39
(2H, m), 1.18 (1H, d, J = 13.0 Hz), 0.90 (3H, s). C (125 MHz, CDCl3) 167.7, 137.6, 128.5,
127.9, 127.5, 122.0 (t, J = 27.7 Hz), 111.78, 80.6, 72.3, 62.0, 39.9, 38.9, 35.6, 35.2, 29.8,
24.2 (t, J = 19.5 Hz), 21.6. LRMS (ESI) m/z [M + H]+ 300.
Reactions of pyrrolo[1,2-a]azepines 3e and 13-15
(1S,8R,9aR)-8,9a-Diallyl-1-(benzyloxy)octahydro-3H-pyrrolo[1,2-a]azepin-3-one (28). The
title compound was prepared in a similar fashion to 5a/6a above, from 3e (0.075 g, 0.27
mmol), allyltrimetylsilane (0.047 g, 0.41 mmol), CH2Cl2 (5 mL) and BF3•Et2O (0.058 g, 0.41
mmol). The crude product was purified by column chromatography (1:2 EtOAc/petrol)
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yielding the title compound (0.031 g, 34%) as a colourless oil.

+ 63.9 (c 0.2 CHCl3).

vmax/cm-1 2922, 1717, 1665, 1470, 1072, 734, 690. H 7.41 – 7.29 (5H, m), 5.92 (1H, m),
5.66 – 5.56 (1H, m), 5.07 (1H, d, J = 9.0 Hz), 5.01 (3H, m), 4.64 (1H, d, J = 12.0 Hz), 4.46
(1H, d, J = 12.0 Hz), 4.02 (1H, d, J = 13.5 Hz), 3.88 (1H, t, J = 9.0 Hz), 2.59 (1H, t, J = 13.5
Hz), 2.55 – 2.40 (3H, m, CH2CH=CH2), 2.21 (1H, dd, J = 14.0, 8.0 Hz), 2.00 – 1.93 (1H, m),
1.90 (1H, d, J = 14.0 Hz), 1.86 (1H, dd, J = 14.0, 7.0 Hz), 1.79 – 1.73 (1H, m), 1.66 (1H, dd,
J = 14.0, 2.0 Hz), 1.46 – 1.40 (1H, m), 1.39 – 1.27 (2H, m), 1.06 (1H, m). C 171.1, 136.7,
133.9, 128.6, 128.0, 127.8, 127.7, 119.1, 116.9, 77.1, 72.4, 67.0, 43.5, 42.5, 39.9, 39.5, 37.3,
36.5, 34.2, 28.5. HRMS (ESI) m/z calcd for C22H30NO2 [M + H]+ 340.2213, found 340.2216.
Key NOESY correlation between H1 (3.88 ppm) and H9 (1.90 ppm)
2-((Trimethylsilyl)methyl)-2,3,9,10-tetrahydro-7H-furo[3,2-d]pyrrolo[1,2-a]azepin-7-one
(29). The title compound was prepared in a similar fashion to 5a/6a above, from 13 (0.070 g,
0.24 mmol), allyltrimethylsilane (0.033 g, 0.29 mmol), CH2Cl2 (5 mL) and BF3•Et2O (0.067
g, 0.48 mmol). Column chromatography (1:4 EtOAc/petrol) of the crude product gave the
title compound (0.033 g, 51%) as a bright yellow oil. vmax/cm-1 2930, 1657, 1362, 1219, 748,
693. H (300 MHz) 6.87 (1H, d, J = 5.5 Hz), 6.01 (1H, d, J = 5.5 Hz), 5.57 (1H, s), 4.84 –
4.73 (1H, m), 3.98 – 3.82 (2H, m), 2.96 (1H, dd, J = 13.5, 9.5 Hz), 2.63 (2H, s), 2.47 (1H, dd,
J = 13.5, 8.0 Hz), 1.28 – 1.17 (1H, dd, J = 14.0, 7.5 Hz), 1.05 (1H, dd, J = 14.0, 8.5 Hz), 0.07
(9H, s). C 170.5, 160.7, 137.1, 136.7, 119.3, 110.1, 106.3, 81.6, 41.0, 37.2, 28.6, 25.4, 0.9.
HRMS (ESI) m/z calcd for C15H22NO2Si [M + H]+ 276.1316, found 276.1319.
2,2-Dimethyl-2,3,9,10-tetrahydro-7H-furo[3,2-d]pyrrolo[1,2-a]azepin-7-one (30). The title
compound was prepared in a similar fashion to 5a/6a above, from 13 (0.070 g, 0.24 mmol),
methallyltrimethylsilane (0.037 g, 0.29 mmol), CH2Cl2 (5 mL) and BF3•Et2O (0.067 g, 0.48
mmol). Column chromatography (1:3 EtOAc/petrol) of the crude product gave the title
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compound (0.023 g, 45%) as a bright yellow oil. vmax/cm-1 2971, 1652, 1618, 1452, 1337,
1264, 1190, 747. H 6.87 (1H, d, J = 5.5 Hz), 6.02 (1H, d, J = 5.5 Hz), 5.55 (1H, s), 3.95 –
3.87 (2H, m), 2.72 – 2.64 (2H, br s), 2.63 (2H, dd, J = 7.0, 3.0 Hz), 1.40 (6H, s). C 170.6,
160.0, 137.3, 136.8, 119.5, 110.4, 106.0, 86.2, 45.8, 38.6, 29.0, 28.4. HRMS (ESI) m/z calcd
for C13H16NO2 [M + H]+ 218.1156, found 218.1160.
(2R,3aS,5S,10aR)-5-(Benzyloxy)-2-((trimethylsilyl)methyl)-2,3,3a,5,6,9,10,10a-octahydro7H-furo[3,2-d]pyrrolo[1,2-a]azepin-7-one (31). The title compound was prepared in a
similar fashion to 5a/6a above from 15 (0.060 g, 0.20 mmol) and allyltrimetylsilane (0.071 g,
0.62 mmol), CH2Cl2 (2 mL) and BF3•Et2O (0.056 g, 0.40 mmol). The crude product was
purified by column chromatography (1:3 EtOAc/petrol) yielding the title compound (0.036 g,
47%) as a colorless oil.

+ 11.6 (c 0.2 CHCl3). vmax/cm-1 2923, 1715, 1671, 1430, 1338,

1219, 912, 693. H 7.33 (5H, m), 4.81 (1H, d, J = 5.0 Hz), 4.55 (2H, s), 4.35 (1H, d, J = 7.0
Hz), 4.10 (1H, t, J = 8.5 Hz), 4.03 – 3.92 (1H, m), 3.92 – 3.83 (1H, m), 3.26 (1H, m), 3.17 –
3.03 (1H, m), 2.62 (1H, dd, J = 17.0, 7.0 Hz), 2.49 (1H, d, J = 17.0 Hz), 2.28 (1H, dd, J =
12.0, 7.4 Hz), 2.07 – 1.92 (1H, m), 1.91 – 1.78 (1H, m), 1.34 (1H, m), 1.09 (1H, dd, J = 14.0,
5.5 Hz), 0.81 (1H, dd, J = 14.0, 9.0 Hz), 0.06 – -0.07 (9H, s). C 170.5, 137.1, 136.2, 128.4,
127.5, 126.9, 106.9, 81.4, 76.7, 75.3, 71.2, 45.3, 41.0, 37.8, 37.4, 29.6, 24.5, -0.93. HRMS
(ESI) m/z calcd for C22H32NO3Si [M + H]+ 386.2148, found 386.2144. Key NOESY
correlations between H3a (3.17-3.03 ppm) and H10a (4.10 ppm) and H2 (3.92-3.83 ppm).
(1S,7S,9aR)-1-(Benzyloxy)-1,2,6,7-tetrahydro-3H,5H-7,9a-epoxypyrrolo[1,2-a]azepin-3-one
(32). The title compound was prepared in a similar fashion to 5a/6a above from 14 (0.050 g,
0.17 mmol), allyltrimetylsilane (0.059 g, 0.51 mmol), CH2Cl2 (2 mL) and BF3•Et2O (0.048 g,
0.34 mmol) at 0 oC. The resulting reaction mixture was stirred at 0 oC for 30 min. The crude
product was purified by column chromatography (1:1 EtOAc/petrol) yielding the title
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+ 21.6 (c 0.1 CHCl3). vmax/cm-1 2925 1717,

compound (0.037 g, 80%) as a colorless oil.

1675, 1338, 1219, 907, 698. H 7.38 – 7.27 (5H, m), 6.53 (1H, d, J = 5.8 Hz), 6.35 (1H, d, J =
5.8 Hz), 4.88 (1H, s), 4.64 (1H, d, J = 11.7 Hz), 4.55 (1H, d, J = 11.7 Hz), 4.26 (1H, dd, J =
8.0, 5.0 Hz), 3.94 (1H, dd, J = 13.0, 7.1 Hz), 3.07 (1H, td, J = 13.0, 5.5 Hz), 2.80 (1H, dd, J =
17.5, 8.0 Hz), 2.47 (1H, dd, J = 17.5, 5.0 Hz), 2.12 – 2.04 (1H, m), 1.45 (1H, dd, J = 13.0, 5.5
Hz). C 169.5, 137.4, 133.8, 128.6, 128.0, 127.8, 127.6, 102.4, 79.4, 76.0, 72.4, 37.0, 34.1,
24.7. HRMS (ESI) m/z calcd for C16H18NO3 [M + H]+ 272.1287, found 272.1275. Key
NOESY correlation between H9 (6.35 ppm) and CH2Ph (4.64 ppm).
(1S,7R,8S,9aS)-8-Allyl-1-(benzyloxy)hexahydro-3H,5H-7,9a-epoxypyrrolo[1,2-a]azepin-3one (33). Method A: The title compound was prepared in a similar fashion to 5a/6a above
from 32 (0.020 g, 0.07 mmol), allyltrimethylsilane (0.014 g, 0.11 mmol), CH2Cl2 (1 mL) and
BF3•Et2O (0.015 g, 0.11 mmol). The crude product was purified by column chromatography
(1:2 EtOAc/petrol) yielding the title compound (0.016 g, 75%) as a colorless oil. Method B:
To a solution of 14 (0.050 g, 0.17 mmol) and allyltrimethylsilane (0.059 g, 0.51 mmol) in
CH2Cl2 (2 mL) was added BF3.Et2O (0.048 g, 0.34 mmol) dropwise at 0 oC. The resulting
mixture was stirred at 0 oC for 2 h and then at rt for 3 h. The crude product was purified by
column chromatography (1:2 EtOAc/petrol) yielding the title compound (0.040 g, 76%) as a
colorless oil.

+ 61.6 (c 0.4 CHCl3). vmax/cm-1 2923, 1715, 1671, 1430, 1338, 1219, 912,

693. H 7.41 – 7.28 (5H, m), 5.87 – 5.73 (1H, m), 5.14 – 5.02 (2H, m), 4.60 (2H, s), 4.42 –
4.35 (1H, m), 4.12 (1H, dd, J = 7.5, 4.5 Hz), 4.01 (1H, dd, J = 13.0, 7.5 Hz), 3.11 (1H, td, J =
13.0, 5.0 Hz), 2.73 (3H, m), 2.62 – 2.53 (1H, m), 2.43 (1H, dd, J = 17.0, 4.5 Hz), 2.33 – 2.26
(2H, m), 1.93 (1H, m), 1.63 – 1.54 (2H, m). C 170.1, 137.4, 136.7, 128.6, 128.1, 127.8,
116.3 , 99.5, 78.0, 77.4, 76.4, 39.5, 36.7, 35.2, 34.5, 33.5, 23.7. LRMS (ESI) m/z 314 [M +
H]+. Key NOESY correlation between H7 (4.42-4.35 ppm) and H8 (2.62-2.53 ppm).
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Synthesis of compounds 41–44.
(1S,7R)-1-(Benzyloxy)-7-(propa-1,2-dien-1-yl)-1,5,6,7-tetrahydroindolizin-3(2H)-one

(41).

The title compound was prepared in a similar fashion to 5a/6a above from 33 (0.124 g, 0.47
mmol), trimethylpropargylsilane (0.064 g, 0.57 mmol), CH2Cl2 (5 mL) and BF3•Et2O (0.135
g, 0.95 mmol). Column chromatography (1:2 EtOAc/petrol) of the crude product gave the
title compound (0.054 g, 42%) as a colorless oil and as a mixture of diastereomers (66:33). A
small amount of major isomer could be obtained in pure form by further separation by
column chromatography. Major diastereomer:

+ 94.2 (c 0.8 CHCl3). vmax/cm-1 2922,

1957, 1706, 1352, 1028, 1004, 642. H 7.44 – 7.29 (5H, m), 5.20 (1H, dt, J = 6.0, 4.5 Hz),
5.09 (1H, s), 4.85 – 4.78 (2H, s), 4.68 (1H, d, J = 12.0 Hz), 4.61 – 4.55 (2H, m), 3.63 (1H, dd,
J = 12.0, 6.0 Hz), 3.55 (1H, m), 3.04 (1H, s), 2.72 (1H, dd, J = 17.5, 7.5 Hz), 2.55 (1H, d, J =
17.5 Hz), 1.94 – 1.84 (1H, m), 1.81 – 1.72 (1H, m). C 207.4, 171.7, 139.3, 137.5, 128.6,
128.0, 127.9, 104.3, 93.3, 77.1, 71.8, 70.9, 37.4, 36.9, 31.5, 26.6. HRMS (ESI) m/z calcd for
C18H20NO2 [M + H]+ 282.1517, found 282.1521. Minor isomer (in part from 1H NMR
spectrum of the mixture): H 5.28 (1H, t, J = 6.5 Hz), 5.01 (1H, s), 4.87 (2H, s), 4.60 (1H, d, J
= 11.5 Hz).
(1S,7S,10aR)-1-(Benzyloxy)hexahydro-3H-7,10a-metahnopyrrolo[1,2-a]azocine-3,9(10H)dione (42). The major diastereomer of 41 (0.021 g, 0.06 mmol) was dissolved in formic acid
(0.5 mL) and the solution was heated at 60 oC for 5 h. The formic acid was evaporated in
vacuo then the crude product was dissolved in CH2Cl2 (5 mL) which was then washed with a
saturated aqueous solution NaHCO3 (3.0 mL), H2O (3.0 mL) and a saturated aqueous solution
of NaCl (3.0 mL). The organic layer was dried over MgSO4, concentrated in vacuo and
subjected to column chromatography (2:1 EtOAc/petrol) to afford the title product (0.011 g,
57%) as a colorless oil.

+ 50.3 (c 0.1 CHCl3). vmax/cm-1 1714, 1662, 1369, 1070, 1008,
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692. H 7.40 – 7.28 (5H, m), 4.64 (1H, d, J = 12.0 Hz), 4.46 (1H, d, J = 12.0 Hz), 4.07 (1H,
dd, J = 14.5, 6.0 Hz), 3.77 (1H, t, J = 6.5 Hz), 2.68 (3H, m), 2.61 – 2.53 (3H, m), 2.45 (1H,
dd, J = 17.5, 5.5 Hz), 2.41 (1H, d, J = 17.5 Hz), 2.05 (1H, d, J = 13.5 Hz), 1.98 (1H, d, J =
13.5 Hz), 1.76-1.63 (1H, m), 1.60 (1H, d, J = 14.0 Hz). C 208.9, 170.3, 137.5, 128.7, 128.2,
127.7, 78.1, 72.1, 64.6, 51.5, 46.1, 36.1, 34.7, 32.2, 29.9, 29.0. HRMS (ESI) m/z calcd for
C18H22NO3 [M + H]+ 300.1518, found 300.1517. Key NOESY correlation between H1 (3.77
ppm) and H10 (2.41 ppm)
(1S,7R)-1-(Benzyloxy)-7-(E)-styryl)-1,5,6,7-tetrahydroindolizin-3(2H)-one (43). The title
compound was prepared in a similar fashion to 5a/6a above from 3a (0.050 g, 0.19 mmol),
(E)--styrylboronic acid (0.034 g, 0.23 mmol), CH2Cl2 (3 mL) and BF3•Et2O (0.055 g, 0.38
mmol). Column chromatography (1:1 EtOAc/petrol) of the crude product gave the title
compound (0.029 g, 45%) as a colorless oil and as a mixture of diastereomers (66:33). A
small amount of major isomer could be obtained in pure form by further separation by
column chromatography. Major diastereomer:

- 14.7 (c 1.3 CHCl3). vmax/cm-1 2922,

1683, 1412, 1071, 915, 743. H 7.40 – 7.20 (10H, m), 6.41 (1H, d, J = 15.8 Hz), 6.14 (1H,
dd, J = 15.8, 7.3 Hz), 5.09 (1H, d, J = 3.5 Hz), 4.66 – 4.57 (3H, m), 3.66 – 3.51 (2H, m), 3.20
(1H, br. s), 2.72 (1H, dd, J = 17.5, 7.5 Hz), 2.55 (dd, J = 17.5, 2.5 Hz), 1.99 (1H, m), 1.73 –
1.63 (1H, m). C 171.7, 139.7, 137.5, 137.1, 132.3, 130.6, 128.6, 128.0, 127.9, 127.4, 126.2,
104.0, 71.8, 70.9, 37.4, 36.7, 35.6, 26.8. HRMS (ESI) m/z calcd for C23H24NO2 [M + H]+
346.1769, found 346.1772. Minor isomer (in part from 1H NMR spectrum of the mixture): H
6.50 (1H, d, J = 14.6 Hz), 4.98 (1H, s), 4.55 (1H, t, J = 6.6 Hz), 3.82-3.76 (2H, m).
(1S,7S,8aR)-1-(Benzyloxy)-7-((E)-styryl)hexahydroindolizin-3(2H)-one (44). The enamide 43
(0.024 g, 0.06 mmol) was dissolved in AcOH (1 mL) and NaCNBH3 (0.021 g, 0.34 mmol)
was added portionwise at rt. The resulting reaction mixture was stirred at rt for 18 h.
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Saturated aqueous solution of NaHCO3 (3 mL) was added and the aqueous layer was
extracted with CH2Cl2 (2x2 mL). The combined organic layers was dried over MgSO4 and
concentrated in vacuo. The crude product was purified by column chromatography (1:2
EtOAc/petrol) yielding the title compound (0.015 g, 75%) as a colorless oil.

- 23.1 (c

1.4 CHCl3). vmax/cm-1 2923, 1685, 1405, 1181, 932, 704. H 7.39 – 7.20 (10H, m), 6.42 –
6.38 (1H, d, J = 16.0 Hz), 6.10 (1H, dd, J = 16.0, 7.0 Hz), 4.58 (1H, d, J = 11.7 Hz), 4.52
(1H, d, J = 11.7 Hz), 4.23 (1H, dd, J = 13.0, 3.5 Hz), 3.91 – 3.86 (1H, m), 3.54 (1H, dt, J =
13.0, 3.5 Hz), 2.80 – 2.67 (2H, m), 2.50 (1H, dd, J = 17.0, 5.0 Hz), 2.39 (1H, m), 2.13 (1H, d,
J = 13.0 Hz), 1.82 (1H, d, J = 13.0 Hz), 1.32 – 1.22 (1H, m), 1.10 (1H, q, J = 13.0 Hz). C
170.7, 137.7, 137.4, 133.3, 129.1, 128.7, 128.5, 128.1, 127.8, 127.4, 126.2, 77.4, 71.7, 62.8,
39.2, 38.9, 37.8, 37.4, 30.7. HRMS (ESI) m/z calcd for C23H26NO2 [M + H]+ 348.1974, found
348.1977. Key NOE correlations between H1 (3.91-3.86 ppm) and H8 (1.10 ppm); H8 (2.13
ppm) and H8a (3.54 ppm); and H7 (2.39 ppm) and CH2Ph (4.52 ppm).
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